Category: Guides

  • The 90-Day Marketing Plan for a New Peptide Brand

    By the Peptide Marketing team, iComChain LLC · Last updated: 16 November 2026

    If you are working out how to market a peptide brand from a standing start, the order matters more than the tactics. Research-use-only (RUO) peptide stores that launch ads before their site, catalogue and payments are ready tend to meet disapprovals, suspensions or processor problems that cost weeks. This guide is a week-by-week 90-day plan for owners and marketers of new RUO stores. It puts the 18 guides in our series in order, so each phase points to the guide that covers it in depth. It is general information, not legal advice, and it contains no client results or industry benchmarks.

    Key takeaways
    • Weeks 1-2 are compliance and payments. No ad money is spent until site copy, product risk tiers and a backup processor are in place.
    • Weeks 3-4 build measurement. Conversion tracking, Merchant Center and product pages come before campaigns, because bidding depends on them.
    • Weeks 5-8 launch paid search carefully: brand and low-risk terms, a tight negative list, Shopping for eligible products, email flows, then Microsoft Ads.
    • Weeks 9-12 add automation and retention: Performance Max, remarketing, promotions, reviews, content for AI search, then a budget and agency review.
    • Each phase ends with a gate. If the gate is not met, extend the phase rather than moving on.

    1. Start here: every guide in the series by theme

    This page is the hub of the series. Use the plan below for the order; use these links for the detail. Every guide is written for RUO stores and keeps to research-use framing.

    2. The 90-day timeline at a glance

    Twelve weeks, four phases. Black rows are gates: checks that must pass before the next phase starts. The dates are a planning shape, not a promise; approvals and reviews take as long as they take.

    The 90-day plan: weekly milestones

    Phase 1 Weeks 1-2: foundations

    W1Site and copy compliance review; RUO terms and checkout acknowledgement
    W2Product risk tiers; primary and backup processor; dispute alerts
    GateEvery live product tiered; payments tested end to end

    Phase 2 Weeks 3-4: measurement

    W3GA4 and Google Ads purchase tracking; enhanced conversions; consent
    W4Merchant Center and feed; product pages with COAs
    GateTest order recorded with correct value; feed reviewed

    Phase 3 Weeks 5-8: launch

    W5Brand and low-risk Search; negative keyword list
    W6Shopping for eligible products; welcome and abandoned-cart email
    W7Search-term and policy review; post-purchase email
    W8Microsoft Ads import and checks
    GateStable approvals; conversion data building

    Phase 4 Weeks 9-12: scale

    W9Performance Max (if gate met); remarketing lists
    W10First promotion; reorder and review requests
    W11AI search and content plan; first pages live
    W12Budget review; agency or in-house decision
    Day 90Review against break-even ROAS and CAC

    Planning template only. If a gate is not met, extend that phase before starting the next.

    How to use this plan

    Name one owner for each week’s milestones and put the gate checks in your calendar. If your store is already trading, start with the first gate you cannot pass today; there is no need to redo work that already meets it. If you sell in several countries, check each platform’s location-specific rules for every market before the phase that uses that platform.

    3. Weeks 1-2: compliance, risk tiers and payments

    The first two weeks decide whether anything after them can run. Ad platforms, processors and email providers all review your site, so it must be ready before any of them see it.

    Week 1: site and catalogue compliance review

    Work through our RUO website compliance checklist page by page. The aim is a site where nothing suggests human use: no dosing, no benefit claims, no before-and-after language, and a clear research-use statement on product pages, at checkout and in your terms. Have a lawyer who knows your market review the result; we are not lawyers, and this plan is not legal advice.

    Review more than the product pages. Check the home page, category pages, blog posts, image alt text, FAQ, email templates, social profiles and any marketplace listings, because platforms and processors can review all of them. Remove old posts that discuss human use rather than editing around them, and keep a dated record of what was changed and why. That record makes a later appeal or processor review faster.

    Week 2: product risk tiers and the payment stack

    Not every product can be advertised. Google’s Healthcare and medicines policy says it does not allow the promotion of certain products “regardless of any claims of legality”, including everything on its non-exhaustive list of unapproved pharmaceuticals and supplements. Sort your catalogue into tiers (for example: can be advertised, organic and email only, not promoted at all) using our product-by-product risk guide. Those tiers drive your keyword lists, feed exclusions and promotions later.

    Example tierPaid search and ShoppingEmail and contentPromotions
    Tier 1: can be advertisedYes, after policy checkYesYes
    Tier 2: organic onlyNo; excluded from feed and keywordsYes, to opted-in contactsEmail only
    Tier 3: not promotedNoCatalogue listing onlyNo

    The tier names are an example; your own tiers should follow the risk guide and your lawyer’s advice.

    In the same week, set up payments so one processor decision cannot stop sales. Our chargebacks guide covers dispute thresholds, alerts and a backup processor, and our peptide payment processing page explains how we approach underwriting.

    Gate 1

    Every live product has a risk tier, every page has passed review, and a test order has gone through both the primary and backup processor. If not, keep working on phase 1. If an account is limited anyway, start with our suspension recovery guide.

    4. Weeks 3-4: tracking, Merchant Center and product pages

    Paid campaigns are only as good as the data they learn from. Phase 2 builds the measurement and the product data that ads will use.

    Week 3: conversion tracking

    Set up purchase tracking in GA4 and Google Ads, with the same purchase value everywhere (decide whether it includes tax and shipping, and keep to that). Add enhanced conversions and a consent setup that fits the markets you sell to. Our conversion tracking guide walks through GA4, enhanced conversions and server-side tagging. Place real test orders and check that each appears once, with the right value. Test a discount code, a multi-item cart and a refund as well, since these are where values most often go wrong. Write down which events count as conversions for bidding and which are only observed, so later reports are read the same way.

    Week 4: Merchant Center, feed and product pages

    Create or clean up Merchant Center and build the feed from your tiered catalogue: products you will not advertise stay out. Our Shopping feed guide covers titles, categories and disapproval fixes; if the account is already limited, see our Merchant Center recovery service. At the same time, bring product pages up to our product page template: lot-matched COAs, specifications, storage information, RUO statement and clear shipping and refund terms.

    Gate 2

    A test order shows up in GA4 and Google Ads once, with the correct value. The feed has been reviewed with any disapprovals understood. Product pages for tier-one products are finished.

    5. Weeks 5-8: paid search, Shopping, email and Microsoft Ads

    Phase 3 is the launch. Keep it narrow: a small set of campaigns you can watch daily is better than wide coverage you cannot police.

    Week 5: Search on brand and low-risk terms

    Start with your brand name and terms our keyword research guide rates as lower risk, with its negative keyword list applied from day one. Ad copy should describe the store (testing, COAs, shipping, support), not effects. Our Google Ads for peptides service page explains how we set accounts up.

    Week 6: Shopping and the first email flows

    Turn on Shopping for eligible products only (see our Google Shopping for peptides page). In parallel, launch a welcome series and an abandoned-cart email. The FTC’s CAN-SPAM compliance guide says commercial email must include a valid physical postal address and a clear way to opt out, and that opt-outs must be honoured within 10 business days. Our peptide email marketing page covers flows and platform choice. Check SMS rules before adding it: our SMS guide lists which platforms accept the category.

    Week 7: review search terms and policy status

    Read the search terms report, add negatives for anything with human-use or treatment intent, and check every ad, keyword and product for policy status. Add a post-purchase email that sends lot and COA information and support contacts.

    What to watch every day in phase 3
    • Policy status of every ad, keyword, asset and product, and any new email from Google about the account.
    • Search terms that suggest human use, dosing or treatment, added as negatives the same day.
    • Conversions recorded against orders in the store, so a tracking break is caught within a day.
    • Disputes and refunds, so a rising rate is visible before it reaches a processor threshold.

    Week 8: Microsoft Ads

    Once Google campaigns are stable, import them into Microsoft Advertising and check each item against Microsoft’s own policies, which differ from Google’s. Our Microsoft Ads guide covers policy, setup and import settings. Add the Microsoft conversion tag and test it the same way as in week 3, and check scheduled imports so they do not overwrite budgets or exclusions you set in Microsoft. Keep Microsoft campaigns small until their own policy status is stable.

    Gate 3

    No unexplained disapprovals for two weeks, conversions recording daily, and email flows sending. Note your conversion count: Google’s Target ROAS page says Search and Shopping campaigns need at least 15 conversions in the past 30 days to use Target ROAS bidding.

    6. Weeks 9-12: Performance Max, retention, content and review

    Phase 4 adds the tools that work best once you have data, customers and a stable account.

    Week 9: Performance Max and remarketing

    Google describes Performance Max as one campaign with access to all Google Ads inventory (YouTube, Display, Search, Discover, Gmail and Maps) that can complement keyword-based Search campaigns. That reach is also why it needs care in this category: your creative appears in places you did not choose. Launch it only if gates 1-3 are met, with the policy-safe assets in our Performance Max guide. Build remarketing audiences within the limits in our remarketing guide; it explains which targeting restrictions apply in this category.

    Week 10: promotions, reorders and reviews

    Run a first, simple promotion from our promotions calendar, for tier-one products only. Start reorder reminders and review requests using our retention guide; reviews must be moderated so none make human-use claims. Ask for reviews after delivery, about the order, packaging, documentation and service, and never offer an incentive tied to a positive rating. If you plan an affiliate programme, read our affiliate guide first.

    Week 11: AI search and content

    Plan content that answers researchers’ questions about specifications, testing, storage and handling. Clear, well-structured pages can be cited in AI answers; our AI search guide explains how. Start with a short list of pages: one per product family covering specifications and testing, a COA and lot lookup page, and a storage and handling page. Each page goes through the same compliance review as product pages, and none should discuss effects or use in people. For short video, check our TikTok guide: most product content is not allowed.

    Week 12: budget review and agency decision

    Compare results with the break-even ROAS and CAC you worked out from your margin, using our marketing budget guide. Look at each campaign separately: a blended ROAS can hide one campaign losing money behind another that is doing well. Count new customers separately from reorders, and include agency or staff costs in CAC. Then decide who runs the next 90 days, using the comparison in the next section.

    7. Day-90 review: what to measure and who should run it

    At day 90 you should have enough data to judge each channel against your own numbers, not industry averages. The table shows what each phase should have produced.

    PhaseShould exist by the endHow to checkIf it is missing
    1. FoundationsReviewed site, risk-tiered catalogue, two working processorsReview notes; tier list; test orders on bothPause paid growth until fixed
    2. MeasurementAccurate purchase tracking; reviewed feed; finished product pagesTest orders match in GA4, Ads and the storeDo not trust ROAS figures yet
    3. LaunchSearch, Shopping, Microsoft Ads and core email flowsPolicy status; conversions by campaignKeep scope narrow; fix before adding
    4. ScalePMax (if eligible), remarketing, retention flows, content planROAS on extra spend; repeat-order rateMove budget back to proven campaigns
    Common ways the plan goes wrong
    • Ads before gate 1. Campaigns launch while old blog posts or reviews still make human-use claims.
    • Tracking taken on trust. Nobody places a test order, so bidding learns from wrong values.
    • Feed includes everything. Products that were never eligible create disapprovals that pull attention from the ones that are.
    • Too many launches at once. Search, Shopping, PMax and Microsoft start in one week, so nobody can tell what caused a problem.
    • No backup processor. One account review stops all sales while ad spend continues.

    Doing it yourself vs. agency help

     In-houseSpecialist agencyHybrid
    Best whenYou already know RUO ad policyYou want the first 90 days set up fastAn agency sets up, staff run day to day
    Main riskLearning policy by trial and errorPaying for work you could doUnclear ownership
    Cost to compareSalary, tools, time, coverSetup and monthly feesSmaller fee plus staff time
    Numbered checklist: day-90 review
    1. Re-run the compliance review on any page or product added since week 1.
    2. Re-check risk tiers against current platform policies.
    3. Confirm tracking accuracy with a fresh test order.
    4. Compare each campaign with your break-even and target ROAS.
    5. Calculate CAC for new customers only, including fees and staff time.
    6. Read the search terms report and update negatives.
    7. Check dispute rates with both processors and confirm volume limits before scaling.
    8. Measure repeat orders from the first customers.
    9. List disapprovals from the 90 days and what fixed each one.
    10. Set the next 90 days’ budget and decide who runs it.

    8. FAQ

    How do you market a peptide brand?

    In order: make the site and catalogue compliant, set up payments with a backup, build tracking and product data, then launch narrow paid search, Shopping for eligible products and email, and only then add Performance Max, remarketing and content. Each step depends on the one before.

    Can I run Google Ads for an RUO peptide store?

    Sometimes, for some products. Google does not allow promotion of products on its unapproved substances list, regardless of claims of legality. Check each product against the policy and run only what is eligible.

    Why wait until week 9 for Performance Max?

    It runs across all Google inventory and relies on conversion data. Starting it before tracking is accurate and approvals are stable means less control and less to learn from.

    What if my account is suspended during the 90 days?

    Stop adding campaigns, find the policy cited, fix the site or catalogue, and then appeal. Our suspension recovery guide covers the steps.

    Do I need email marketing from the start?

    Yes. A welcome series and abandoned-cart email should run from the first paid traffic, following CAN-SPAM rules on postal address and opt-outs.

    How much budget does the plan need?

    We do not publish a figure. Work out break-even ROAS from your own margin, size tests from the conversions they need, and keep fixed costs such as testing and compliance review outside the ad budget.

    Can the plan be faster than 90 days?

    Sometimes, if your site is already compliant and tracking works. Do not skip a gate: each one checks something the next phase depends on.

    Want help with the 90 days?

    Plan your first quarter with us

    Peptide Marketing works only with research-use-only peptide brands. On a short call we will look at where your store is in this plan and what we would do next. No invented benchmarks.

    Book a 15-min call

    Prefer email? Write to hello@peptidemarketing.info.

    Sources

    General information for businesses selling research-use-only products, not legal or financial advice. Sources read on 16 November 2026; platform rules change often.

  • How to Choose a Peptide Marketing Agency (and When Not to Hire One)

    By the Peptide Marketing team, iComChain LLC · Last updated: 16 November 2026

    Choosing a peptide marketing agency is harder than choosing an agency for most online stores. Research-use-only (RUO) peptides sit close to Google’s healthcare and unapproved-substance rules, card processors treat the category as high risk, and one wrong shortcut can cost you an ad account, a Merchant Center account or a merchant account. This is an honest buyer’s guide for owners and marketers of RUO peptide stores: what a good agency in this category should know, what to ask on a discovery call, how pricing models shape behaviour, the red flags to walk away from, who should own your accounts, and when you are better off not hiring anyone yet. It contains no dosing, efficacy or human-use information.

    Key takeaways
    • Category knowledge beats general skill. A good agency can explain Google’s healthcare and circumvention policies, Merchant Center rules and how payments limit growth, without hand-waving.
    • Every pricing model rewards something. Know whether yours rewards more spend, more hours or a finished deliverable.
    • Walk away from “guaranteed approval”, new accounts to get around a ban, or cloaking. Google’s own policy treats these as grounds for suspension without warning.
    • You should own every account: Google Ads, Merchant Center, analytics, email and SMS platforms, and the data in them. The agency gets access, not ownership.
    • Reporting should show Google’s own cost figures, separate from agency fees. For third parties that resell or manage Google ads, that is a Google requirement, not a courtesy.
    • Sometimes the right answer is “not yet”: without a compliant site, enough budget to learn from, and working tracking, an agency mostly spends money.

    1. What a good peptide marketing agency should know

    A capable general ecommerce agency can still do real damage in this category. The skills that matter most are not creative or bidding skills; they are knowing where the lines are and building inside them. Test for four areas.

    Platform policies

    Google’s Healthcare and medicines policy bans the promotion of items on its non-exhaustive list of unapproved pharmaceuticals and supplements “regardless of any claims of legality”, along with products marketed as safe or effective for a disease without government approval, and speculative or experimental treatments. The policy page does not name research peptides, which is exactly why judgement matters. A good agency should be able to tell you which of your products it would not advertise, explain why, and point you to the policy text. Our product-by-product risk guide shows the kind of reasoning to expect.

    They should also know the Circumventing systems policy well enough to tell you what they will never do (see red flags), and how an appeal after a suspension actually works.

    Merchant Center

    Shopping needs a healthy Merchant Center account, and in this category that is often where the trouble starts. Ask how they handle product disapprovals, feed titles and categories, and the site requirements in Google’s editorial and professional requirements (return policy, contact details, a working checkout). They should also know that under Merchant Center’s abuse of the network policy, a suspended Google Ads account linked to your Merchant Center account is itself a violation. Our Shopping feed guide covers the feed side.

    Payments

    Ad spend is useless if your processor caps volume or closes the account. A peptide agency does not need to be a payments expert, but it should understand that scaling traffic raises chargeback and refund exposure, that descriptors and checkout wording matter, and that growth plans should be paced to what your merchant account can carry. If they never ask about your processor, they are planning without a key constraint. See our chargebacks and processor redundancy guide.

    Site compliance and tracking

    Ads are reviewed against the landing page. An agency should audit your site for RUO labelling, human-use language, COA pages and policies before spending a dollar, using something like our RUO website compliance checklist. It should also insist on working conversion tracking; our conversion tracking guide explains why.

    A quick test

    Ask any agency: “Which of our products would you refuse to advertise, and which words on our site would you remove first?” A specific answer, with reasons, tells you more than a deck of case studies.

    2. Questions to ask on a discovery call

    A discovery call should feel like a two-way audit. Bring these questions, and listen for specifics rather than reassurance.

    QuestionGood answer sounds likeWorrying answer sounds like
    Which peptide or RUO accounts have you run, and what went wrong?Honest account of disapprovals or suspensions and what they changed“Nothing has ever gone wrong”
    What will you do if our Google Ads account is suspended?Fix the cause, then appeal in the existing account; explains that new accounts after suspension break policy“We’ll just open a new account”
    Which of our products and pages would you change before launch?Names products, claims and pages, with policy reasons“Your site looks fine”
    Whose name is on the Google Ads, Merchant Center and analytics accounts?Yours, with the agency added as a user or linked manager“We run everything in our own accounts”
    What will reporting show, and how often?Platform cost, clicks, impressions and conversions, with fees shown separatelyA blended “results” figure with no source data
    Who will actually work on our account?Named people, their experience and how to reach themVague; senior staff on the sales call, then unknown juniors
    How do you handle our payment limits?Asks about processor, volume caps and disputes before planning spendNever asks
    What happens when we leave?Access removed, assets and data stay with you, a written handoverNotice periods, fees or “the account belongs to us”

    Also ask for references you can call, a sample report with client details removed, and a written scope. If an agency cannot describe its first 30 days of work, it does not yet know your business well enough to price it.

    3. Pricing models and what each incentivises

    There is no correct price for this work, and we do not quote benchmarks here because published figures vary too much to be useful. What you can judge is the incentive each model creates, and whether it suits your stage.

    ModelHow it worksWhat it rewardsWatch forBest fit
    Monthly retainerFixed fee for an agreed scope each monthKeeping you as a client; predictable workloadScope drift, little visible work, long minimum termsOngoing management with steady work
    Percentage of ad spendFee is a share of what you spend on the platformsHigher spend, whether or not it is profitablePressure to raise budgets; little reward for cutting wasteLarger accounts where spend is already proven
    Flat project feeFixed price for a defined deliverable (audit, setup, feed rebuild, appeal preparation)Finishing the deliverableThin scope; nothing after hand-offAudits, setups, recoveries, one-off fixes
    Hybrid (base plus percentage)Lower base fee plus a share of spend above a thresholdSome stability plus growthHard to compare; check the total at your realistic spendGrowing accounts
    Performance or revenue shareFee tied to sales or conversionsReported conversionsAttribution disputes, pressure on claims, access to your sales dataRarely suits a policy-sensitive category

    Two points apply to all of them. First, Google’s transparency requirements for third parties say that if a partner charges a management fee separate from Google’s charges, it must tell new customers in writing before the first purchase and show the fee on invoices; where monthly reporting is required, costs must be reported as the amount Google charged, excluding the partner’s fees. Second, in a high-risk category the best result in a given month can be less spend: pausing a risky campaign or product protects the whole account. Make sure the pricing model does not punish the agency for telling you that.

    Compare like with like

    Ask each agency to state the total monthly cost at your realistic spend, the minimum term, what is included, and what is billed extra (creative, landing pages, feed work, tracking). Put the answers side by side. See our pricing page for how we set out our own terms.

    4. Red flags

    Some warning signs are matters of taste. These are not; each one either breaks platform policy or leaves you exposed.

    Guaranteed approvals or results

    No one outside Google can guarantee that ads, products or an appeal will be approved, and Google’s third-party policy tells partners to avoid “false, misleading, or unrealistic claims” and to be honest about costs and expected results. “We have a way to get peptides approved” usually means one of the next two flags.

    Churning new accounts or cloaking

    Google’s Circumventing systems policy says you can’t create more Google Ads accounts after a suspension to get around its policies, and bans cloaking: showing different content to Google than to users to hide things. Suspensions under this policy happen on detection and without prior warning, and linked accounts can be affected. Merchant Center’s abuse of the network policy likewise bans creating new accounts to re-enter Shopping after a suspension and manipulating site content to bypass automated checks. An agency that offers these tactics is offering you a short run and a permanent ban, often tied to your business details, domain and payment profile. The third-party policy also lists enabling circumvention as a prohibited practice for agencies themselves.

    Holding accounts or data hostage

    If the agency creates the Google Ads, Merchant Center, analytics or email accounts under its own name, you may lose your campaign history, audiences, conversion data and customer lists when you leave. Ask before you sign, and get the answer in the contract.

    Vague reporting

    A monthly PDF with “impressions up, engagement strong” is not reporting. You should see platform cost, clicks, impressions, conversions and revenue by campaign, the source of each figure, what changed and why, and any policy warnings or disapprovals. Google’s transparency requirements oblige partners covered by them to give customers their Google Ads customer IDs on request; you should never need to ask twice.

    The agency scorecard

    Score each 0 (no), 1 (partly), 2 (clearly yes)

    Explains Google healthcare and circumvention policy in specifics012
    Has a Merchant Center process: feed, disapprovals, site requirements012
    Asks about your processor, limits and disputes012
    Audits site compliance and tracking before spend012
    You own every account; agency gets user access012
    Reports platform costs with fees shown separately012
    Named team, references you can call012
    Clear exit: short notice, written handover012

    Red-flag checklist: any tick = walk away

    Guarantees approval, reinstatement or results
    Offers new accounts after a suspension
    Suggests cloaking or “safe” landing pages for Google
    Runs ads in agency-owned accounts only
    Won’t share platform cost data or customer IDs
    Recommends human-use or dosing claims “for conversion”
    Charges to release your data or access

    13–16 strong fit · 9–12 ask follow-up questions · 0–8 keep looking. A red flag overrides any score.

    5. Contracts and account ownership

    The rule is simple: the business owns the accounts, the agency gets access. This protects you if the relationship ends, if the agency’s own accounts are ever suspended, or if a key person leaves.

    • Google Ads. Create the account under a company email you control. Google’s access levels page shows that only Admin access can unlink manager accounts and change access levels, so keep at least one Admin user on your side (Google suggests more than one). Link the agency’s manager account or add its staff as users. Google’s third-party policy also requires a separate account for each advertiser an agency manages, so your campaigns should never sit inside a shared account.
    • Merchant Center. In Google’s people and access levels model, Admin users can add and remove people, while Standard users cannot manage others. Keep Admin yourself; give the agency Standard or Admin as needed.
    • Analytics. In GA4, the Administrator role has full control, including managing users. Keep it on your side and give the agency Editor or Marketer unless it needs more.
    • Email and SMS platforms, tag manager and any server-side tracking. Same principle: your billing, your login, agency as a user. Your subscriber lists are customer data and should never live only in an agency’s tool.
    • Creative and copy. Agree that ads, landing pages and assets made for you are yours to keep and reuse.
    Numbered checklist: before you sign
    1. Every account is in the company’s name, on a company email, with billing on your card or invoice.
    2. You hold Admin access on Google Ads, Merchant Center, GA4, tag manager, email and SMS.
    3. The scope is written: channels, deliverables, meetings and what is billed extra.
    4. Fees are stated separately from platform spend, and invoices show them.
    5. Reporting is defined: metrics, source, frequency and access to live dashboards.
    6. A compliance clause: no circumvention, no cloaking, no new accounts after suspension, no human-use or dosing claims, and you approve all copy.
    7. Policy notices are shared with you promptly: warnings, disapprovals, suspensions.
    8. Notice period and minimum term are ones you can live with.
    9. Exit terms: access removed, a written handover of campaigns, tracking and open issues, and no fee to keep your own data.
    10. Confidentiality covers your customer data, supplier details and margins.

    Have a lawyer review the contract. This guide is general information, not legal advice.

    6. When not to hire an agency yet

    An agency multiplies what you already have. If the base is not ready, it multiplies the problems. Wait, or hire for a narrow project first, if any of these are true.

    Your site is not compliant

    If product pages describe human use, mention doses, or rely on outcome language, ads will be disapproved or worse, and no campaign skill fixes that. Fix the site first. A flat-fee audit can help; ongoing management cannot.

    Your budget is too small to learn from

    Management fees take a share of the budget before any of it reaches the platform, and campaigns need enough clicks and conversions for anyone to judge what works. If your total marketing budget would mostly go on fees, you will learn little. Spend it on your site, product documentation, email to existing customers and organic content first, and revisit paid media once you can fund spend and fees together for several months. Our peptide marketing budget guide helps you set that number.

    You have no tracking

    Without reliable conversion tracking, neither you nor the agency can tell whether anything is working, and automated bidding has nothing to learn from. Set up GA4 and platform conversions first, or make tracking the agency’s first project.

    Your payments cannot carry growth

    If your processor is already close to its limits, or disputes are high, more traffic can put the merchant account at risk. Sort out payment processing and backup options before you scale.

    Doing it yourself in the meantime

    Many early-stage stores do better by fixing compliance, building a clean Merchant Center feed, and setting up email flows in-house, then bringing in specialists for a defined project. Our guides on keyword research and product page templates are written for exactly that.

    7. FAQ

    What should a peptide marketing agency know that a general agency might not?

    Google’s healthcare, unapproved substances and circumventing systems policies, Merchant Center site and feed requirements, how payment processors limit growth in a high-risk category, and how to keep RUO site and ad copy free of human-use and dosing claims.

    Is it safe to hire an agency that promises guaranteed Google approval?

    No. Nobody outside Google can guarantee approval, and Google’s third-party policy tells partners to avoid unrealistic claims. Guarantees in this category often mean new accounts after a ban or cloaking, which Google treats as grounds for suspension without warning.

    Which pricing model is best for a peptide store?

    It depends on your stage. Flat project fees suit audits, setups and recoveries. Retainers suit steady ongoing work. Percentage of spend can reward higher budgets regardless of profit. Compare the total cost at your realistic spend and the minimum term.

    Who should own our Google Ads and Merchant Center accounts?

    Your business. Create the accounts under a company email, keep Admin access yourself, and give the agency user access or link its manager account. Do the same for analytics, tag manager, email and SMS platforms.

    What should agency reports include?

    Platform cost, clicks, impressions, conversions and revenue by campaign, with agency fees shown separately, plus what changed, why, and any policy warnings or disapprovals. You should also be able to log in to the accounts yourself.

    Can an agency get a suspended Google Ads account back?

    It can help you find and fix the cause and prepare an appeal in the existing account, but it cannot guarantee reinstatement. Google says egregious circumvention suspensions are reinstated only in compelling circumstances.

    When should a peptide brand not hire an agency?

    When the site is not yet compliant, when the budget would mostly go on fees, when there is no conversion tracking, or when the payment processor cannot carry more volume. Fix those first, or hire for a defined project.

    Talk to us

    Want a second opinion on your agency shortlist, or on us?

    Peptide Marketing works only with research-use-only peptide brands, across Google Ads, Google Shopping, Merchant Center recovery, email marketing and payment processing. Score us with the checklist above. Your accounts stay in your name, and we will tell you if you are not ready for an agency yet. See our results and pricing.

    Book a 15-min call

    Prefer email? Write to hello@peptidemarketing.info.

    Sources

    General information for businesses selling research-use-only products, not legal or financial advice. Sources read on 16 November 2026; platform policies change often.

  • Peptide Marketing Budget: What to Spend and Where

    By the Peptide Marketing team, iComChain LLC · Last updated: 16 November 2026

    A peptide marketing budget has to cover more than ads. Research-use-only (RUO) peptide stores carry fixed costs most shops never see, such as lot testing, compliance review and processor reserves, and they work with fewer channels that will accept them. This guide gives owners and marketers of RUO stores a framework for deciding what to spend and where at three stages: pre-launch, early traction and scaling. It shows how to work out break-even ROAS, customer acquisition cost (CAC) and payback from your own margin. We have not used industry averages or client results: every number below is an illustrative example, and the inputs that matter are yours. This is general information, not financial advice.

    Key takeaways
    • Budget fixed costs first. Testing, COAs, compliance review, tools and the cash a processor holds back come before any ad spend.
    • Your break-even ROAS comes from your margin: 1 ÷ contribution margin. No benchmark can tell you this number.
    • Pre-launch money goes on foundations (site compliance, tracking, email capture, content), not on ads that may be disapproved.
    • Testing budgets buy information; scaling budgets buy volume. Keep them in separate lines with separate rules.
    • Tell your processor before you scale. Stripe lists a sharp, unexplained rise in volume as one reason it may place a reserve.
    • Compare agency and in-house on total cost, including tools, ramp-up time and cover, not on the fee alone.

    1. Fixed costs specific to RUO peptide stores

    Before you decide on an ad budget, list the costs you will pay whether or not a single ad runs. In this category they are larger and less predictable than in general e-commerce, and several of them grow with your catalogue rather than your sales.

    Fixed costWhat it coversWhat makes it growBudget note
    Compliance reviewLegal review of site copy, RUO terms, checkout acknowledgements, policies and new product pagesNew SKUs, new channels, rule changesBudget a review for every new product page and every new channel, not just launch
    Lab testing and COAsThird-party testing of each lot and publishing the certificate of analysisNumber of SKUs × lots per yearGet quotes from your lab; cost scales with lots, so faster stock turnover means more tests
    ToolingStore platform, email and SMS platform, reviews, analytics and server-side tagging, SEO plugin, feed toolContacts, sends, orders, seatsMany tools price by list size or volume; re-check costs at each stage
    Processor feesTransaction fees, chargeback fees, monthly and gateway fees from a high-risk processorSales volume and dispute rateUse the rates in your own merchant agreement in the margin calculation below
    Rolling reserveA share of each day’s sales held back by the processor for a set periodSales volume and risk reviewNot a cost, but cash you cannot spend on marketing until it is released
    Account recovery timeAppeals and fixes when ads, Merchant Center or a processor account is limitedPolicy changes, catalogue changesKeep a contingency line; see Merchant Center recovery

    Why reserves belong in a marketing budget

    Stripe’s reserves FAQ describes a reserve as a temporary hold on a portion of a business’s funds to cover expected disputes and refunds. Among the reasons it may place one, it lists industries with longer delivery windows, elevated dispute activity and “an unexplainable and sharp increase in processing volume”. High-risk processors set their own terms; yours will be in your agreement.

    Illustrative example

    Suppose a processor holds 10% of sales for 180 days (invented terms, not a typical rate). A store selling $30,000 a month has $3,000 a month withheld. After six months about $18,000 is held at any one time. That is $18,000 of cash that cannot fund ads or stock, even though the store is profitable. If you plan to double ad spend, plan for the reserve to grow with it.

    Our chargebacks guide covers dispute thresholds and backup processors, and our peptide payment processing page explains how we approach underwriting.

    2. Break-even ROAS, CAC and payback (worked example)

    Three numbers decide how much you can afford to spend to win a customer. All three come from your own data.

    Step 1: contribution margin per order

    Start with average order value (AOV), then subtract every cost that moves with an order: product cost, processor fees, fulfilment (shipping you pay minus shipping you charge, plus packaging) and an allowance for refunds and chargebacks.

    Contribution per order = AOV − product cost − processor fees − fulfilment − refund/chargeback allowance
    Contribution margin = contribution per order ÷ AOV

    Step 2: break-even and target ROAS

    ROAS is revenue divided by ad spend. Google’s Target ROAS help page writes it as a percentage: $5 in sales for $1 in spend is 500%.

    Break-even ROAS = 1 ÷ contribution margin
    Target ROAS = 1 ÷ (contribution margin − target profit margin)

    Step 3: CAC and payback

    CAC = total marketing spend in a period ÷ new customers in that period
    Payback (orders) = CAC ÷ contribution per order
    Payback (months) = CAC ÷ average monthly contribution per customer
    Illustrative example: invented numbers

    These figures show the arithmetic only. They are not benchmarks, client results or predictions.

    Line (illustrative)ValueWorking
    Average order value$100From your store data
    Product cost$25Landed cost incl. testing per unit
    Processor fees$55% of AOV (illustrative rate)
    Fulfilment$10Shipping and packaging, net of shipping charged
    Refund/chargeback allowance$22% of AOV
    Contribution per order$58100 − 25 − 5 − 10 − 2
    Contribution margin58%58 ÷ 100
    Break-even ROAS1.72 (172%)1 ÷ 0.58
    Target ROAS for 15% profit2.33 (233%)1 ÷ (0.58 − 0.15)
    CAC$75$6,000 spend ÷ 80 new customers
    Payback in orders1.3 orders75 ÷ 58
    12-month contribution per customer$104$58 × 1.8 orders (illustrative)

    Here the first order does not pay back the $75 CAC; the second order does. Whether that is acceptable depends on how reliably customers reorder, which you can measure by cohort (see our retention guide).

    Make platform ROAS match your formula

    Ad platforms report ROAS on the conversion value you send them. If that value includes tax or shipping, or if returning customers are counted as new, platform ROAS will look better than your real return. Decide what the purchase value includes and send it the same way everywhere; our conversion tracking guide shows how.

    3. Budget by stage: pre-launch, early traction, scaling

    The right split changes as you move from no data to enough data to bid on. Use the stage you are actually in, not the one you hope to reach.

    Pre-launch

    Goal: build what every later channel depends on. Spend goes on a compliant site (our RUO website compliance checklist), product pages with COAs (our product page template), tracking, email capture and a first set of content. Paid search, if any, is limited to brand terms and a small test once accounts and products are approved. Check which products can be advertised before planning any spend on them: see which peptides can be advertised.

    Early traction

    Goal: find out which campaigns can reach your break-even ROAS. Most new spend goes into Google Search and Shopping where products are eligible, with Microsoft Ads added once Google campaigns are stable. Email flows start paying for themselves because every order adds to the list.

    Scaling

    Goal: add volume while staying above target ROAS and inside your processor’s limits. Raise budgets on proven campaigns, widen Shopping coverage, and invest more in content that keeps working without bids. Retention matters more here because CAC usually rises as you reach beyond your best audiences.

    Illustrative example: share of marketing budget by channel at each stage

    Pre-launch

    Foundations first; little or no paid traffic

    SEO and content45%
    Email/SMS setup30%
    Google Ads/Shopping15%
    Microsoft Ads0%
    Testing reserve10%

    Early traction

    Paid search proves or disproves break-even

    SEO and content20%
    Email/SMS15%
    Google Ads/Shopping45%
    Microsoft Ads10%
    Testing reserve10%

    Scaling

    More volume on what is proven

    SEO and content15%
    Email/SMS10%
    Google Ads/Shopping50%
    Microsoft Ads15%
    Testing reserve10%

    Illustrative example only, not a benchmark or recommendation. Fixed costs from section 1 sit outside these percentages. Set your own split from your margin, eligibility and results.

    4. What each channel costs and returns

    The table compares channels on the things that matter for a budget: how you pay, how fast it returns, and the policy risk specific to RUO peptides.

    ChannelHow you paySpeed of returnRUO policy riskBudget role
    Google SearchPer click, plus management timeFast once approvedHigh: keyword and landing-page policiesMain paid channel at traction and scale
    Google ShoppingPer click; feed upkeepFast for eligible productsHigh: product disapprovals are commonScale where products are eligible
    Microsoft AdsPer clickFast, usually smaller volumeSeparate policies from GoogleSecond paid channel once Google is stable
    EmailPlatform fee by list size, plus content timeImmediate on existing listLower; platform terms varyRetention and reorders at every stage
    SMSPlatform and per-message feesImmediate on opted-in listHigh: many platforms and carriers restrict the categoryOptional, only on a platform that accepts you
    SEO and contentWriting, editing and compliance timeSlow, compoundingLow if copy stays within RUO framingSteady share; builds traffic no one can switch off

    Two platform rules affect budget planning. Google says a campaign may spend up to twice its average daily budget on a given day, but no more than 30.4 times the daily budget across the month, so set daily budgets from your monthly limit. Microsoft says in its budget options page that campaigns pause when they reach the daily limit, and that automated imports from Google Ads reset settings, including budget, to the Google values. If you import on a schedule, change budgets in Google Ads or check your import settings so changes are not overwritten. Our Microsoft Ads guide covers setup, and the Shopping feed guide covers eligibility. For SMS, check our SMS marketing guide before budgeting anything.

    Budgeting SEO and content

    SEO and content are easy to cut because they show no return in the first month. For an RUO store they are also the channel least exposed to ad disapprovals and account limits. Budget them as a steady monthly amount rather than whatever is left over, and judge them over quarters, not weeks. Count the full cost: writing, compliance review of each page, and updates when products, lots or rules change. Pages that answer research buyers’ questions clearly can also be cited in AI search answers; our AI search guide covers how. Track organic revenue and new customers from organic search separately, so the content line can be compared with paid channels on the same CAC basis.

    5. Testing budgets vs. scaling budgets

    A testing budget buys information: does this campaign, product or audience reach break-even? A scaling budget buys volume from something already proven. Mixing them leads to cutting tests too early or scaling things that were never proven.

    Sizing a test

    A test needs enough conversions to judge. Google’s Target ROAS page says Search and Shopping campaigns need at least 15 conversions in the past 30 days to use that strategy. A simple way to size a monthly test is to multiply the conversions you need by the CAC you can accept:

    Monthly test budget ≈ conversions needed × acceptable cost per conversion

    Illustrative example: 15 conversions × $58 (break-even on the first order, from section 2) = $870 for the month. If you cannot afford that, test fewer things at once rather than spreading too little across many.

    Giving tests time

    Google says a “Learning” status can show for up to 7 days after a new bid strategy or a major structural change, and that performance typically settles within 1 to 2 conversion cycles. It also says budget changes do not trigger “Learning”. Set the test length and the pass/fail line before you start, and do not judge a test inside its first conversion cycle.

     Testing budgetScaling budget
    PurposeLearn whether something can reach break-evenAdd volume above target ROAS
    SizeFixed amount or share, set in advanceGrows with proven results and cash
    Success measurePass/fail against a line set before launchROAS, CAC and payback holding as spend rises
    When to stopAt the planned end date, pass or failWhen marginal ROAS falls below target
    Outside limitsPolicy approval of the ad and productProcessor volume limits and reserves
    Scale in steps, and warn your processor

    Raise budgets on proven campaigns in planned steps and watch ROAS on the extra spend, not the average. Before a big step, tell your processor and confirm any monthly volume cap in your agreement. A sudden jump that your processor did not expect can lead to a reserve or a review at the worst moment.

    6. Agency vs. in-house cost structures

    Compare the total cost of each option, not just the headline fee. An agency fee usually covers specialists you would otherwise hire separately; an in-house hire gives you full-time focus but needs tools, training and cover for holidays and departures.

    Cost elementAgencyIn-houseHybrid
    Main costSetup fee plus monthly fee, often a share of ad spend or flatSalary, benefits, payroll costsSmaller agency scope plus one internal owner
    ToolsSome included; check the contractYou pay for every seatSplit by who uses them
    Ramp-upShorter if the agency knows RUO policyLonger; policy knowledge has to be learnedAgency sets up, staff run day to day
    Cover and continuityTeam cover built inRisk if one person leavesKnowledge shared between both
    Fit by stagePre-launch and early tractionScaling with steady volumeMoving from traction to scale

    For a sense of in-house cost, the US Bureau of Labor Statistics gives a 2025 median pay of $165,780 a year for advertising, promotions and marketing managers. That is a manager-level figure across all industries, before benefits; specialist roles and your location will differ. Our own fees are on our pricing page: fixed setup fees and a Google Ads management fee that falls as a share of spend as spend grows. Whichever you choose, add the fee to the CAC calculation in section 2.

    7. The budget-setting checklist

    Numbered checklist
    1. List every fixed cost from section 1 with a monthly or per-lot figure from your own quotes.
    2. Read your merchant agreement for fees, reserve terms and any monthly volume cap.
    3. Calculate contribution per order and margin from your own AOV and costs.
    4. Work out break-even and target ROAS and write them down before any campaign launches.
    5. Check that conversion values are sent the same way your formula counts revenue.
    6. Confirm product and ad eligibility before budgeting paid spend on a product.
    7. Decide your stage and set a channel split for it.
    8. Separate the testing line and size each test from the conversions it needs.
    9. Set daily budgets from monthly limits, allowing for Google’s 2× daily and 30.4× monthly rules.
    10. Measure CAC and payback monthly by new-customer cohort, including agency or staff costs.
    11. Plan reserve cash before each scaling step and tell your processor.
    12. Review the split every quarter and move money towards what beats target ROAS.

    8. FAQ

    How much should a peptide store spend on marketing?

    There is no reliable industry figure for RUO peptide stores, and we do not publish one. Start from your contribution margin: your break-even ROAS tells you the most you can spend per dollar of sales, and fixed costs and reserves tell you how much cash is available.

    How do I calculate break-even ROAS?

    Divide 1 by your contribution margin. If each order leaves 58% of its value after product, fees, fulfilment and refunds (an illustrative example), break-even ROAS is 1 divided by 0.58, or about 1.72 (172%).

    What is the difference between CAC and cost per conversion?

    Cost per conversion counts every purchase an ad platform reports, including returning customers. CAC divides total marketing spend by new customers only, so it shows what it really costs to grow your customer base.

    Should I spend on ads before launch?

    Mostly no. Before launch, money is usually better spent on a compliant site, tracking, product pages with COAs and email capture. Paid spend is limited to brand terms and small tests once accounts and products are approved.

    How big should a testing budget be?

    Big enough to reach a decision. Multiply the conversions you need by the cost per conversion you can accept. Google requires at least 15 conversions in 30 days for Target ROAS on Search and Shopping.

    Is a rolling reserve a marketing cost?

    No, it is cash held back by your processor and usually released later. It still matters for your budget, because money held in reserve cannot be spent on ads or stock, and reserves can grow as sales grow.

    Is an agency cheaper than hiring in-house?

    It depends on your spend and stage. Compare total cost: agency fees against salary, benefits, tools, ramp-up time and cover. Add whichever you choose to your CAC.

    Want a second opinion?

    Set a budget from your own numbers

    Peptide Marketing works only with research-use-only peptide brands. On a short call we will go through your margin, break-even ROAS, channel eligibility and stage, and tell you where we would put the next dollar. No invented benchmarks.

    Book a 15-min call

    Prefer email? Write to hello@peptidemarketing.info.

    Sources

    General information for businesses selling research-use-only products, not financial, legal or tax advice. All example numbers are illustrative. Sources read on 16 November 2026; platform rules change often.

  • Retention for Peptide Stores: Repeat Orders, Reviews and Lifetime Value

    By the Peptide Marketing team, iComChain LLC · Last updated: 16 November 2026

    Peptide customer retention is the work of getting research buyers who ordered once to order again, stay with you and tell others what they found. For a research-use-only (RUO) peptide store it matters more than for most shops: ad accounts get limited, processors cap volume, and every new customer costs more than it should. This guide is for owners and marketers of RUO peptide stores. It covers repeat-order economics and how to calculate lifetime value (LTV), reorder flows, loyalty and subscriptions (including what processors expect of recurring billing), account portals, customer service, and reviews: collecting them, moderating them within the FTC’s rule, answering criticism and marking them up. It contains no dosing, efficacy or human-use information.

    Key takeaways
    • Measure LTV on gross margin, not revenue, and compare it with what a new customer costs you.
    • Reorder reminders built around a buyer’s own order history are the simplest retention win and need no health claims.
    • Subscriptions are a payments decision first. ROSCA, Visa’s trial rules and your processor’s terms set the minimum: clear terms, express consent, simple online cancellation.
    • A portal with order history and the COA for each lot shipped gives buyers a reason to log in and reorder from you.
    • Moderate reviews by content, never by rating. The FTC’s 2024 rule lets you withhold reviews on criteria applied equally to all reviews, not because they are negative.
    • Product review markup only. Google says self-serving reviews of your own business are not eligible for review stars.

    1. Repeat-order economics and LTV

    Every reorder is revenue you did not pay an ad platform for. To manage retention you need three numbers from your own store data, not industry averages.

    • Average order value (AOV): revenue divided by orders, after discounts and refunds.
    • Gross margin: what is left after product cost, payment fees, shipping and packaging, as a percentage.
    • Orders per customer over a fixed period, such as 12 or 24 months, measured by cohort (all customers whose first order fell in the same month).

    The simple formula is: LTV = AOV × gross margin × orders per customer over the period. Compare it with customer acquisition cost (CAC): total marketing spend for a period divided by new customers in that period.

    Illustrative numbers only

    These figures are invented to show the arithmetic. They are not benchmarks, client results or predictions.

    Input (illustrative)Scenario A: few reordersScenario B: better retention
    Average order value$150$150
    Gross margin50%50%
    Orders per customer in 24 months1.42.6
    24-month LTV (gross margin)$150 × 0.5 × 1.4 = $105$150 × 0.5 × 2.6 = $195
    CAC$80$80
    LTV : CAC1.3 : 12.4 : 1

    Same product, same price, same ad spend. Only reorders changed, and the business went from barely covering acquisition to funding it comfortably.

    Accurate inputs need clean data. Our conversion tracking guide covers tagging new versus returning purchases so ad platforms and analytics count them correctly. Also track cohort repeat rate and time between orders by product; the second tells you when to send reorder reminders.

    2. Post-purchase and reorder flows

    Most retention happens in the inbox and by text. The flows below are triggered by what a buyer did, so they stay relevant and need no outcome claims. Timings are starting points; set yours from your own time-between-orders data.

    FlowTriggerSuggested timingWhat to sendRUO guardrail
    Order confirmationOrder placedImmediatelyItems, lot numbers when known, RUO terms accepted, support contactRepeat the research-use-only terms
    Shipping and deliveryLabel created, deliveredOn carrier eventsTracking, storage-on-arrival guidance as published on the label, link to the COA for the lotStorage and handling only; no use instructions
    Review requestDelivered7 to 14 days laterAsk about product quality, packaging, shipping and documentationAsk reviewers not to describe human use or dosing
    Reorder reminderTime since last order of an itemJust before the buyer’s usual reorder intervalOne-click reorder of the same items, current stock and lotNo efficacy or “results” language
    Win-backNo order in 2 to 3 usual intervalsOnce, then a final noteWhat’s new: lots, testing, catalogue, service changesOffer only what your promotions calendar allows

    Email and SMS have different rules. SMS needs prior consent, carrier-approved content and a platform that accepts the category; our SMS marketing guide sets out which platforms allow peptide stores. If you also run paid remarketing, keep the audiences consistent with our remarketing guide so the same buyer is not chased on every channel. Our peptide email marketing service builds and maintains these flows.

    Write it like a supplier, not a supplement brand

    Good reorder copy reads like a lab-supply catalogue: “Your last order of [product] shipped 6 weeks ago. Lot [number] is in stock with its COA. Reorder in one click.” Avoid words such as “results”, “protocol”, “cycle” and “stack”, which imply human use.

    3. Loyalty programmes and subscriptions

    Loyalty schemes and subscriptions both reward repeat buying, but they carry different risks. A subscription bills a card again without a new checkout, so card networks, processors and US law all have something to say about it.

    OptionHow it worksRetention effectPayment and compliance loadBest for
    Reorder remindersBuyer reorders manually after a promptModerate; buyer stays in controlLow: each order is a fresh checkoutEvery store, first
    Points or tiered loyaltyPoints per dollar, redeemable on later orders; tiers for volumeGives a reason to stay; works with manual ordersLow to medium: clear terms, points expiry rules, liability on the booksStores with a broad catalogue
    Volume or institutional pricingPrice breaks for labs that order regularlyStrong for B2B accountsLow; may need invoicingStores with lab and university buyers
    Subscription (auto-ship)Card charged on a schedule until cancelledHighest predictabilityHigh: processor approval, consent records, reminders, cancellation, dispute exposureStable products with steady reorder intervals

    What recurring billing requires

    • ROSCA (US federal law). For online sales with a negative option feature, 15 U.S.C. § 8403 requires you to disclose all material terms clearly before taking billing information, obtain express informed consent before charging, and provide simple mechanisms to stop recurring charges.
    • The FTC’s click-to-cancel rule is not in force. The Eighth Circuit vacated the amended Negative Option Rule on 8 July 2025. The FTC published an advance notice of proposed rulemaking on 13 March 2026 to start again. When we checked on 16 November 2026 we found no proposed rule since; ROSCA enforcement continues meanwhile. State automatic-renewal laws may add requirements; ask counsel which apply to you.
    • Visa’s subscription rules. Visa’s 2020 rules for trials and introductory offers require express consent at enrolment, a confirmation with the terms and a simple online cancellation link, a reminder at least seven days before billing when a trial or introductory price ends or terms change, and an easy way to cancel online. We advise against free trials for RUO products; note that a discounted first shipment is also an introductory offer under these rules.
    • Your processor’s terms. High-risk processors often underwrite recurring billing separately, may require descriptor and cancellation details, and may not allow it for every product category. Ask before you launch, not after the first dispute. Our peptide payment processing page covers how we approach underwriting.
    Subscriptions and chargebacks

    “I didn’t authorise this” disputes on recurring charges are among the easiest to prevent and the hardest to win without records. Keep the consent timestamp, the terms shown, the confirmation and the reminder you sent. Let buyers skip, pause, change the date and cancel in the portal without contacting support. Our chargebacks guide explains why a few avoidable disputes can put a merchant account at risk.

    4. Account portals with order and COA history

    For research buyers, documentation is part of the product. A portal that keeps it in one place is a strong reason to reorder from you rather than search again.

    • Order history with lot numbers. Record the lot shipped against each order line, not just the product.
    • The COA for each lot received, downloadable from the order, matching the public batch page described in our product page template.
    • One-click reorder of a past order, showing the current lot and its COA before checkout.
    • Invoices and receipts for institutional buyers, with purchase-order fields if you sell to labs.
    • Subscription controls, if you offer them: skip, pause, change date, update card, cancel.
    • Saved RUO acknowledgement, renewed at each checkout, so terms are never skipped by a reorder shortcut.

    Keep logged-in pages out of search with noindex and robots rules, and do not put order or customer details in URLs. The site-level requirements are in our RUO website compliance checklist.

    5. Customer service as retention

    Most buyers who leave do so after a problem: a late parcel, a damaged vial, a missing COA, a slow reply. How fast and how fairly you fix it decides whether they come back. Service also protects your payment stack, because a buyer who gets an answer rarely files a dispute.

    • Publish response times and meet them.
    • Tell buyers about delays before they ask.
    • Write a clear policy for damaged, lost and incorrect shipments, and apply it consistently.
    • Make refunds easy to request through support, so a dispute is never the simpler route.
    • Use a fixed script for use questions. Staff should never give dosing, reconstitution-for-use or human-use advice, by email, chat or phone. A short, polite line that the products are sold for laboratory research only, plus a link to the published documentation, is enough.
    • Tag tickets by cause (shipping, damage, documentation, payment) and review them monthly. Repeated causes are retention problems to fix upstream.

    6. Reviews: collecting, moderating and the FTC rule

    Reviews help new buyers decide. For a peptide store they carry a particular risk: a reviewer may describe personal use or doses, and once published on your site, that text reads as your marketing.

    Collecting reviews

    • Ask every verified buyer, not only the ones you expect to be happy.
    • Ask about what you control: purity documentation, packaging, shipping speed, service, value.
    • Say up front that reviews describing human use, dosing or health outcomes cannot be published.
    • Incentives: the FTC rule bans rewards conditioned on a positive or negative review (§ 465.4). If you reward any honest review, disclose it on the review; the Endorsement Guides treat free or discounted products as a material connection.

    The FTC Consumer Reviews and Testimonials Rule

    The FTC’s Rule on the Use of Consumer Reviews and Testimonials (16 CFR Part 465), published in August 2024, is in force. Because it is a trade regulation rule, violations can bring civil penalties. The parts that matter most to a store:

    • Fake reviews (§ 465.2): no reviews by people who don’t exist or didn’t use the product, and no buying or publishing them knowingly.
    • Insider reviews (§ 465.5): officers and managers must disclose their connection, and there are limits on soliciting reviews from staff and their relatives.
    • Company-controlled review sites (§ 465.6): a “review” site you control cannot pose as independent.
    • Review suppression (§ 465.7): no unfounded legal threats, intimidation or knowingly false public accusations to stop or remove a review, and no implying your displayed reviews are all or most of those submitted while you hide reviews for their rating or negative sentiment.
    You may withhold a review when it…You may not withhold or remove a review because it…
    Contains trade secrets or confidential commercial or financial informationGives a low rating
    Is defamatory, harassing, abusive, obscene, vulgar or sexually explicitCriticises shipping, price, service or documentation
    Contains another person’s personal information or likenessCompares you unfavourably with a competitor
    Is discriminatory on race, gender, sexuality, ethnicity or another intrinsic characteristicIs from a buyer who also filed a complaint
    Is clearly false or misleading, or you reasonably believe it is fakeIs inconvenient for a sales campaign
    Is wholly unrelated to your products or services 

    The left column is the rule’s own list of criteria that do not count as suppression, provided they are “applied equally to all reviews submitted without regard to sentiment”.

    Moderating out human-use and dosing claims

    The rule’s list is introduced with “such as”, so it is not exhaustive. A written policy that holds back every review describing human use, dosing or health outcomes, whether the rating is five stars or one, fits the rule’s logic of criteria applied equally regardless of sentiment. Have your counsel confirm it for your store. Three practical rules make it defensible:

    1. Publish the policy next to your reviews, and show how many reviews were withheld under it.
    2. Apply it to positive reviews as strictly as negative ones. Log every decision with the reason.
    3. Ask to edit before you reject. Invite the reviewer to resubmit without the use or dosing content. Never rewrite a review yourself to change its meaning.

    The retention loop, with the review-moderation branch

    1First orderClear RUO terms, confirmation, tracking, COA for the lot shipped.
    2Review request7 to 14 days after delivery, to every verified buyer.
    3ReorderReminder timed to the buyer’s own interval; one-click reorder in the portal.
    4LoyaltyPoints, volume pricing or a compliant subscription; fast, fair service.

    ↻ Loyal buyers reorder and review again: back to step 2

    Branch from step 2: a review arrives. Check content, never the rating.

    PublishHonest review of quality, packaging, shipping, documentation or service, at any star rating.
    Ask to editOtherwise fine but mentions human use, doses or health outcomes. Invite the reviewer to resubmit without it.
    RejectFake, abusive, personal data, clearly false, unrelated, or a use claim the reviewer won’t remove. Log the reason.

    Moderation criteria follow 16 CFR § 465.7(b) and must be applied equally to positive and negative reviews.

    Responding to negative reviews

    • Reply publicly, briefly and calmly: acknowledge the issue, state the fix and invite the buyer to support.
    • Never threaten legal action over an honest review; unfounded threats are exactly what § 465.7(a) bans.
    • Keep order details private. Do not post names, addresses or order contents in a reply.
    • No use advice in replies. If a review raises a use question, the reply repeats the RUO position and stops there.

    Review schema

    Google’s review snippet guidelines (updated 8 September 2026) set the limits:

    • Mark up product reviews on product pages. Nest Review or AggregateRating inside Product markup for the specific item.
    • Not your business as a whole. Google says that if the entity being reviewed controls the reviews about itself, its pages using LocalBusiness or Organization markup are ineligible for review stars, including via embedded widgets.
    • Visible and first-party. Reviews you mark up must be visible on the page, ratings must come directly from users, and you must not aggregate reviews from other websites.
    • Keep it matched. If a review is withheld, remove it from the markup and the count too.

    Review stars in Shopping and ads have their own rules; see our Google Shopping for peptides and Google Ads for peptides services, and Merchant Center recovery if your account is limited.

    7. The retention checklist

    Numbered checklist
    1. Calculate AOV, gross margin and 24-month orders per customer by cohort from your own data.
    2. Calculate CAC for the same period and record LTV : CAC.
    3. Measure time between orders for your top products.
    4. Build confirmation, shipping, review-request, reorder and win-back flows, with RUO wording checked.
    5. Record lot numbers on every order line and link each lot’s COA in the portal.
    6. Add one-click reorder that renews the RUO acknowledgement.
    7. Before any subscription, get processor approval in writing and set up consent records, a 7-day reminder and online cancellation.
    8. Publish service response times and a damaged, lost and incorrect shipment policy.
    9. Give staff a fixed script for use and dosing questions.
    10. Write and publish a review moderation policy based on content, not rating, with logged decisions.
    11. Remove any incentive tied to positive reviews and disclose any incentive for honest reviews.
    12. Audit review markup: Product only, visible, first-party, counts matching.

    8. FAQ

    How do I calculate customer lifetime value for a peptide store?

    Multiply average order value by gross margin and by the average number of orders per customer over a fixed period, such as 24 months, measured by cohort. Compare the result with customer acquisition cost for the same period.

    Can I delete negative reviews on my peptide store?

    Not because they are negative. The FTC rule lets you withhold reviews on criteria applied equally to all reviews, such as abusive content, personal data, clearly false content, fake reviews or unrelated content, but not because of a low rating or negative sentiment.

    Can I remove reviews that mention dosing or human use?

    A written policy that withholds every review describing human use or dosing, positive or negative, fits the rule’s approach of content-based criteria applied equally. Publish the policy, log decisions, ask reviewers to edit first, and have counsel confirm it.

    Can I offer a discount for leaving a review?

    Only if it is not conditioned on the review being positive or negative, and the incentive is disclosed with the review. Rewards for positive reviews only are banned under 16 CFR 465.4.

    Can a peptide store offer subscriptions?

    Possibly, if your processor approves recurring billing for your products. You must disclose material terms before taking billing details, get express informed consent and offer simple cancellation under ROSCA, and follow Visa’s reminder and cancellation rules for introductory offers.

    Is the FTC click-to-cancel rule in effect?

    No. The Eighth Circuit vacated it in July 2025. The FTC restarted rulemaking with an advance notice in March 2026, and ROSCA still applies to online subscriptions in the meantime.

    Can I show star ratings for my store in Google results?

    Not for reviews of your own business. Google says self-controlled reviews on pages with LocalBusiness or Organization markup are ineligible. Product review markup on product pages, with the reviews visible, can be eligible.

    Want a second opinion?

    Grow revenue from the buyers you already have

    Peptide Marketing works only with research-use-only peptide brands. We will review your LTV data, flows, portal, subscription setup and review policy, and give you a prioritised fix list. We never write fake reviews or hide honest ones.

    Book a 15-min call

    Prefer email? Write to hello@peptidemarketing.info.

    Sources

    General information for businesses selling research-use-only products, not legal or financial advice. Sources read on 16 November 2026; rules and platform documentation change often.

  • TikTok and Short Video for Peptide Brands: What Is Allowed

    By the Peptide Marketing team, iComChain LLC · Last updated: 16 November 2026

    TikTok peptide marketing got harder in 2026. Searches for some peptide names on TikTok now return no results, and every major short-video platform has rules that cover drugs, unapproved substances and supplements. This guide is for owners and marketers of research-use-only (RUO) peptide stores who want to know what they can still do on TikTok, YouTube Shorts and Instagram Reels. It covers each platform’s ad policies and community rules, how organic and paid posts differ, what brand and education content stays within the rules, how to work with creators, and what gets accounts banned. It does not cover ways to evade moderation, and it contains no dosing, efficacy or human-use information.

    Key takeaways
    • Selling-oriented peptide content is the risk, not the word “peptide”. TikTok told Endpoints News that discussion is permitted but marketing high-risk products is not.
    • Paid ads for peptide products are effectively closed on all three platforms. Their drug and supplement ad policies leave no route for an unapproved compound.
    • Organic posts have more room, but not for selling. All three ban content that sells or links to sellers of drugs that need a prescription or are unsafe.
    • Branded content has its own ban lists. TikTok and Meta both prohibit paid creator posts for drug-related, pharmaceutical and unsafe-supplement products.
    • What works: company story, lab and quality process, testing explainers, hiring and behind-the-scenes content, with no product claims and no buy links.
    • Disclose every paid relationship, using the platform tool and the FTC’s plain-language rules.

    1. What changed on TikTok in 2026

    On 22 October 2026, eMarketer reported, citing The Verge, that TikTok searches for terms including BPC-157 and retatrutide now return “no results found”, while other peptide searches still surface videos. It was unclear when the restriction began. According to the same report, TikTok told Endpoints News that peptide discussion is permitted, but the platform prohibits marketing high-risk products and may restrict searches for unapproved or potentially unsafe products.

    Three things follow for an RUO brand:

    • Search is not a dependable channel. TikTok can switch off search for any compound name without notice, and the list is not published.
    • The line TikTok drew is between talking and marketing. A video about how a lab verifies purity is discussion. A video that names a compound, shows the vial and points to a store is marketing.
    • Scrutiny is rising across platforms. eMarketer notes that drug makers are pressing platforms to curb sales of unapproved versions of their compounds. Expect the same tightening on YouTube and Instagram.
    Don’t try to beat the filter

    Misspelling compound names, using code words or swapping letters for numbers to get past a search block is evading moderation. TikTok’s account rules list circumventing enforcement as a reason for bans. It also tells a reviewer, or a payment processor reading your profile, that you know the content isn’t allowed. We don’t advise it.

    2. TikTok’s ad, community and branded content rules

    TikTok has three rule sets that matter here, and a post can break one while passing the others.

    Ads

    TikTok’s Dangerous Products or Services ad policy (updated April 2025) bars ads that show or sell illegal, controlled or prescription drugs, and drugs for enhancement, performance or weight loss. Prescription drugs may be allowed only in the US and Canada when approved by the regulator. The Healthcare and Pharmaceuticals policy (updated September 2026) sets market-by-market rules that assume regulatory approval or certification. Neither page names peptides or research chemicals, but an unapproved compound has no approval to show, so we treat product ads as not allowed.

    Community Guidelines

    TikTok’s Regulated Commercial Activities guideline says it doesn’t allow “the trade or marketing of regulated, prohibited, or high-risk goods”. Trade includes selling, giveaways and redirecting people off-platform to buy. It lists prescription and over-the-counter drugs as regulated substances and says it does not allow showing, possessing or using drugs. Marketing that isn’t disclosed with the content disclosure setting is ineligible for the For You feed.

    Branded content

    TikTok’s Branded Content Policy (November 2023) covers any post paid for or otherwise incentivised, including free product, commissions and affiliate links. Its prohibited industries include drug-related products, pharmaceutical and healthcare products (including pharmacological products claiming health benefits), weight loss products and hazardous chemical products. A creator paid to feature a peptide product breaks this policy even if the video makes no claims.

    3. YouTube Shorts rules

    Shorts sit under YouTube’s Community Guidelines, which apply to all types of content on the platform, and under Google’s ad policies when money changes hands.

    • Selling and linking. YouTube’s illegal or regulated goods policy says content intended to sell certain regulated goods is not allowed. The list includes pharmaceuticals without a prescription. It also bans directing viewers to sellers through links, emails or phone numbers, including links in the description and links said aloud in the video.
    • Education exception, with a limit. Educational, documentary, scientific or artistic context can keep a video up, but YouTube says this is not a pass to promote content intended to sell.
    • Paid promotion. YouTube’s paid product placement page requires creators to tick the paid promotion setting, which adds a disclosure label. Paid promotions must also follow Google Ads policies, which restrict unapproved pharmaceuticals and supplements. Our product-by-product risk guide explains how Google treats specific compounds.
    • Strikes. Under YouTube’s strike system, the first violation is usually a warning. Later violations bring strikes that block uploads for one week, then two weeks, and three strikes within 90 days may remove the channel. Severe abuse can end a channel without warning.

    4. Instagram Reels and Meta rules

    Reels follow Meta’s Community Standards for organic posts and Meta’s Advertising Standards for ads and boosts.

    • Ads. Meta’s Drugs and Pharmaceuticals standard says ads can’t promote the sale or use of illicit, recreational or “other unsafe substances, products or supplements, as determined by Meta at its sole discretion”. Prescription drug ads need LegitScript certification or Meta’s internal review, Meta authorisation, an adult audience and eligible countries. Meta’s unsafe supplements list includes anabolic steroids and human growth hormones.
    • Organic posts. Meta’s Restricted Goods and Services standard (updated 9 September 2026) defines prescription drugs as drugs that need a prescription or medical professionals to administer, and does not allow content that attempts to buy, sell or trade them, with narrow exceptions for legitimate healthcare e-commerce. It allows discussing scientific or medical merits and news.
    • Branded content. Meta’s Branded Content Policies prohibit paid creator posts for illegal products, “drugs and drug-related products” and unsafe products and supplements. Pharmacies and prescription drug partners need written pre-authorisation. Creators must use the branded content tool to tag the partner.

    Meta doesn’t name research peptides, and “sole discretion” means a reviewer decides. If a Reel would read as selling a drug to a reasonable viewer, assume it will be treated as one.

    5. Organic vs paid, platform by platform

    Paid placements face the strictest review: ad policies, pre-approval and often LegitScript certification, which RUO compounds can’t obtain. Organic posts face community rules that focus on selling, links and drug use. Branded creator posts sit in between, judged under both.

    FormatTikTokYouTube ShortsInstagram Reels
    Paid ads for peptide productsNot allowed (drug and healthcare ad policies)Not allowed (Google Ads unapproved substances rules)Not allowed (drugs and unsafe supplements standards)
    Paid ads for brand, careers or lab services without productPossible, but reviewed against the advertiser’s sitePossible; landing page reviewedPossible; landing page reviewed
    Paid creator posts featuring productsProhibited industry in Branded Content PolicyMust follow Google Ads policiesProhibited in Branded Content Policies
    Organic posts selling or linking to productNot allowed (trade or marketing of high-risk goods)Not allowed (selling or linking to regulated goods)Not allowed (buying or selling prescription drugs)
    Organic education and company contentAllowed; discussion permittedAllowed, with EDSA contextAllowed; discussion of scientific merit permitted
    Main penaltyRemoval, For You ineligibility, account banWarning, strikes, channel removalRemoval, restricted visibility, rejected ads

    A paid ad for a brand page still sends reviewers to your website. If your site sells peptides with health language, the ad will likely fail. Our RUO website compliance checklist covers what reviewers look for, and the same discipline underpins our Google Ads for peptides and Google Shopping work.

    Allowed / restricted / banned: short video for RUO peptide brands

     
    TikTok
    YouTube Shorts
    Instagram Reels
    Allowed
    TikTokCompany story, lab tours, how testing works, hiring, founder videos with no product claims
    YouTube ShortsEducational or documentary explainers about testing methods and the research supply chain
    Instagram ReelsBehind-the-scenes, quality process, news and discussion of scientific merit
    Restricted
    TikTokNaming compounds: search may be blocked; undisclosed marketing loses For You reach
    YouTube ShortsAny paid promotion: disclosure required and Google Ads policies apply
    Instagram ReelsBranded content: must be tagged; pharmacy and Rx partners need pre-authorisation
    Banned
    TikTokSelling, giveaways or off-platform buy links; showing drug use; product ads; paid creator product posts
    YouTube ShortsContent intended to sell; links or spoken directions to sellers; non-educational how-to-use
    Instagram ReelsBuying, selling or trading drugs; ads for unsafe substances; branded content for drugs or unsafe supplements

    Our reading of each platform’s published policies on 16 November 2026. No platform names RUO peptides; reviewers decide case by case. No dosing, human-use or before/after content on any platform.

    6. Brand and education content that stays within the rules

    The goal on short video is trust and recognition, not direct sales. Buyers who already know your name will find you through search, email and your site. These formats fit within all three platforms’ rules as we read them:

    • Lab and quality process. Receiving inspection, cold storage, labelling, packing for shipping. Film the process, not a hero shot of a named vial.
    • Testing explainers. What HPLC and mass spectrometry measure, how a certificate of analysis (COA) is laid out, why third-party testing matters. Keep it about the method.
    • Company story. Why the company exists, who works there, how it chooses suppliers and labs, what “research use only” means for who it sells to.
    • Industry news, accurately. Regulatory updates and platform changes, explained factually, without telling viewers what to buy or take.
    • Hiring and culture. Job openings and team spotlights are ordinary business content.
    Keep out of every video
    • Dosing, reconstitution, injection or “how I use it” content, including in comments and replies.
    • Before/after images or body-change stories of any kind.
    • Health, recovery, weight, ageing or performance claims, stated or implied.
    • Prices, discount codes, “link in bio to buy” and DMs offering product.
    • Influencers or staff describing personal use.

    A sample week of posts

    1. Monday: a 30-second walk-through of how incoming batches are logged and stored.
    2. Wednesday: “What does HPLC actually measure?” explained on a whiteboard, with no product named.
    3. Friday: a team member on why the company sells for research use only and what that means for who can buy.

    Keep captions as plain as the videos. Hashtags built around compound names or outcomes pull a clean video back into the risky category, and on TikTok some compound-name searches are already restricted.

    Profile links matter too. A bio that links straight to product pages turns educational videos into a sales funnel in a reviewer’s eyes. Link to an about or testing page instead, and grow your list there with a clear opt-in; our peptide email marketing service builds those flows. If you plan to retarget visitors, read our remarketing guide first, because audience rules differ by platform.

    7. Creator partnerships, bans and a checklist

    Working with creators

    Both TikTok and Meta prohibit paid creator posts that promote drug-related products, so a sponsored “review” of a peptide is out on both, whatever the caption says. Partnerships that can work are ones where the creator talks about your company, testing or industry, not a product, and every one must be disclosed.

    • Use the platform tool. TikTok’s content disclosure setting labels posts “Promotional content” or “Paid partnership” and can’t be changed after posting. YouTube uses the paid promotion setting. Meta requires the branded content tool.
    • Disclose in the video too. The FTC’s Disclosures 101 for Social Media Influencers says video endorsements should be disclosed in the video, not only the description, and that creators shouldn’t rely on a platform tool alone. Free product counts as a material connection.
    • No unsupported claims. The FTC says endorsers can’t make claims the advertiser couldn’t prove, such as a health claim.
    • Write it down. A creator brief should list banned topics (use, dosing, results, prices), require disclosure and give you approval before posting. Our affiliate program guide has contract language you can adapt.

    What gets accounts banned

    TikTok’s account rules say bans can follow a single severe violation or repeated violations, and accounts dedicated to the trade or marketing of prohibited goods can be banned. YouTube removes channels after three strikes in 90 days. In practice, the patterns that end accounts are:

    • Videos that show product with a buy link, discount code or “DM to order”.
    • Comment and DM selling, even when the videos themselves are clean.
    • Creators or staff filming personal use or results.
    • Coded names or backup accounts used to get around a block.
    • Undisclosed paid posts, which TikTok can remove or restrict.

    A banned account can also surface in payment reviews. Processors look at public brand presence; see our peptide payment processing page. If a Google account is already limited, start with Merchant Center recovery.

    If a video is removed

    Read the notice, note which policy it cites and appeal through the platform’s own process if you believe the call was wrong. Don’t repost the same video, edited slightly or on a second account. Look for the pattern behind the removal instead: usually a caption, a comment thread or a bio link rather than the footage itself. Fix that across every post before publishing again.

    Numbered checklist
    1. Audit every profile bio and link on TikTok, YouTube and Instagram; point them to an about or testing page.
    2. Remove old posts that show product with prices, codes, use or results.
    3. Turn off any paid campaigns that feature products, and keep paid spend to brand or careers content.
    4. Write a content policy listing allowed formats and banned topics for staff, agencies and creators.
    5. Set up comment and DM moderation so product requests get a neutral reply pointing to your site’s terms.
    6. Plan a four-week calendar of process, testing and company-story videos.
    7. Brief creators in writing with disclosure rules and pre-approval.
    8. Check disclosure on every paid post: platform tool plus on-screen and spoken disclosure.
    9. Log policy notices and appeals in one place so patterns are visible early.
    10. Review this guide’s sources quarterly; all three platforms change these rules often.

    Short video then supports the channels that do convert: search, email and SMS. Our AI search guide and SMS marketing guide cover those.

    8. FAQ

    Can I run TikTok ads for research peptides?

    We treat it as not allowed. TikTok’s ad policies bar ads that show or sell prescription drugs or drugs for enhancement, performance or weight loss, and other health products need regulatory approval, which RUO compounds don’t have.

    Is it against TikTok’s rules to mention peptides at all?

    No. According to eMarketer, TikTok told Endpoints News that peptide discussion is permitted but marketing high-risk products is not. Some compound searches are blocked, so reach is limited.

    Can I put a link to my store in my TikTok or Instagram bio?

    Linking to product pages from accounts that post about peptides risks being read as trade or marketing of high-risk goods. A safer choice is a link to an about or testing page on your site.

    Can I pay creators to review my peptides?

    Not on TikTok or Instagram. Both prohibit branded content for drug-related products. Paid YouTube promotions must follow Google Ads policies, which restrict unapproved pharmaceuticals. Creators can be paid to cover your company or testing process, with disclosure.

    Do YouTube Shorts follow different rules from long videos?

    No. YouTube’s Community Guidelines apply to all content on the platform, so Shorts that sell or link to sellers of regulated goods break the same policy as long videos.

    What happens if a video is removed?

    On YouTube the first violation is usually a warning, then strikes; three strikes in 90 days may remove the channel. TikTok can ban for a single severe violation or repeated ones. Appeal through the platform and fix the pattern first.

    Is using code words for peptide names a good workaround?

    No. It is evading moderation, which TikTok lists as a reason for bans, and it signals to reviewers that you know the content is not allowed.

    Want a second opinion?

    Build a short-video presence that keeps your accounts

    Peptide Marketing works only with research-use-only peptide brands. We will review your TikTok, YouTube and Instagram profiles, flag posts and links that put accounts at risk, and plan content that builds trust within each platform’s rules.

    Book a 15-min call

    Prefer email? Write to hello@peptidemarketing.info.

    Sources

    General information for businesses selling research-use-only products, not legal or regulatory advice. Sources read on 16 November 2026; platform policies change often.

  • AI Search for Peptide Brands: Getting Cited by ChatGPT and Google AI

    By the Peptide Marketing team, iComChain LLC · Last updated: 16 November 2026

    Peptide AI search optimization means making a research-use-only (RUO) peptide store easy for ChatGPT search, Google AI Overviews and AI Mode, Perplexity and Copilot to find, understand and cite, without gaming them. Buyers now ask these tools which suppliers publish third-party testing or how to read a certificate of analysis (COA), and the answers link to a handful of sources. This guide is for owners and marketers of RUO peptide stores. It explains what each company documents about how its answers pick sources, which crawlers to allow, how to write pages worth citing, how to keep brand facts consistent, how to take part in communities honestly, and how to measure the result. Nobody can promise an AI citation, and we don’t. It contains no dosing, efficacy or human-use information.

    Key takeaways
    • AI answers are built on search indexes. Google says a page must be indexed and eligible for a snippet to appear in AI Overviews or AI Mode. OpenAI says sites must allow OAI-SearchBot to be eligible for ChatGPT search.
    • Training bots and search bots are separate. You can block GPTBot or Google-Extended and still be eligible for ChatGPT search and Google Search.
    • No special file or markup is required. Google says you don’t need AI text files or special schema for its AI features.
    • Citable pages answer one question plainly and back it with evidence: batch COAs, testing methods, policies and consistent business facts.
    • Astroturfing backfires. In 2026, r/biohackers moderators banned new peptide posts after sellers spammed the community to influence AI answers.
    • Track it like a channel: AI referrals in analytics, Search Console, Bing’s AI Performance report and a fixed log of test prompts.

    1. How AI answers find and cite sources

    There is a lot of speculation about “how AI picks sources”. We stick to what the companies document, which is less than the industry claims but enough to act on.

    • ChatGPT search. OpenAI’s help page says ChatGPT sometimes partners with third-party search providers and typically rewrites a question into one or more targeted queries. It ranks results “using multiple factors” and says placement is not guaranteed. To be eligible, a site must allow OAI-SearchBot and its host or CDN must allow OpenAI’s published IP addresses.
    • Google AI Overviews and AI Mode. Google’s AI features page says both may use “query fan-out”, running related searches across subtopics, then display supporting links. A page must be indexed and eligible to show with a snippet. There are no extra technical requirements, and AI Overviews often don’t trigger at all.
    • Perplexity. Its help center says it searches the web in real time, summarises what it finds and adds numbered citations to the original sources. Its crawler page says PerplexityBot is used to surface and link sites in results.
    • Microsoft Copilot and Bing. Microsoft reports citations from Copilot, Bing and select partner AI experiences in the AI Performance report in Bing Webmaster Tools.

    How an AI answer selects sources, and where a brand can legitimately appear

    1QuestionA user asks, for example, how to read a peptide COA.
    Where a brand can appearA real buyer question you have actually answered on your site.
    2Query rewriteThe engine turns it into one or more search queries (fan-out).
    Where a brand can appearPlain wording that matches the subtopics people ask about.
    3RetrieveIt pulls candidate pages from a search index built by crawlers.
    Where a brand can appearSearch bots allowed in robots.txt and the CDN; pages indexed.
    4Select and summariseIt ranks candidates and writes the answer from them.
    Where a brand can appearA clear answer up top, with evidence: COAs, methods, data.
    5CiteIt links the pages it used. Placement is never guaranteed.
    Where a brand can appearYour own page, or an independent mention you earned honestly.

    Based on OpenAI, Google and Perplexity documentation read on 16 November 2026. Each engine works differently and changes often.

    The practical point: steps 2 to 4 are the same machinery as ordinary search. If a page is blocked, unindexed, thin or vague, no AI-specific trick fixes it. That is why our RUO website compliance checklist and our product-page work come before anything labelled “AI”.

    EngineWhat it documents about sourcesYour controlWhere to measure
    ChatGPT searchRewrites queries, may use partner search providers, ranks on multiple factorsAllow OAI-SearchBot and OpenAI’s IP rangesAnalytics referrals from chatgpt.com
    Google AI Overviews / AI ModeQuery fan-out; page must be indexed and snippet-eligibleGooglebot in robots.txt; nosnippet, max-snippet, noindexSearch Console Performance, “Web” search type
    PerplexityReal-time web search with numbered citationsAllow PerplexityBot and its IP rangesAnalytics referrals from perplexity.ai
    Copilot / BingCitations across Copilot, Bing and partnersBingbot access; Bing Webmaster ToolsBing AI Performance report

    2. Crawler access and robots.txt

    Each AI company runs more than one bot, and they do different jobs. Mixing them up is the most common mistake we see: a store blocks “AI bots” wholesale to keep its content out of training and drops out of AI search with it.

    User agentCompanyPurpose (as documented)Follows robots.txt?Our default for RUO stores
    OAI-SearchBotOpenAISurfaces sites in ChatGPT search. Opted-out sites are not shown in search answers, though they can still appear as navigational linksYes; changes take about 24 hoursAllow
    GPTBotOpenAICrawls content that may be used to train OpenAI’s foundation modelsYesYour choice; no effect on ChatGPT search
    ChatGPT-UserOpenAIVisits a page when a user’s request needs it; not automatic crawling, not used for search inclusion“May not apply”Don’t block at the firewall
    GooglebotGoogleCrawls for Google Search, including AI Overviews and AI ModeYesAllow
    Google-ExtendedGoogleA robots.txt token controlling use for Gemini training and grounding in Gemini Apps and Vertex AI; no separate crawlerYes (token only)Your choice; no effect on Google Search
    PerplexityBotPerplexitySurfaces and links sites in Perplexity results; not used for foundation-model trainingYes; up to 24 hoursAllow
    Perplexity-UserPerplexityFetches pages for user requests“Generally ignores”Don’t block at the firewall

    Sources: OpenAI crawlers, Google common crawlers, Perplexity crawlers. Google also says it intends to support the AIPREF training-preference signal in early 2027, so check that page again next year.

    A starting robots.txt for a store that wants to appear in AI search but keep its content out of model training looks like this. Treat the two Disallow groups as a business decision, not a ranking tactic:

    User-agent: OAI-SearchBot
    Allow: /
    
    User-agent: PerplexityBot
    Allow: /
    
    User-agent: GPTBot
    Disallow: /
    
    User-agent: Google-Extended
    Disallow: /
    
    User-agent: *
    Disallow: /cart/
    Disallow: /checkout/
    Disallow: /my-account/
    Check the layer above robots.txt

    Google’s AI features page lists making sure crawling is allowed “by any CDN or hosting infrastructure”, and OpenAI and Perplexity both ask you to allow their published IP ranges. Bot-protection settings at your CDN, firewall or host can block a crawler that robots.txt allows. Check those settings, then confirm in your server logs that OAI-SearchBot, PerplexityBot and Googlebot get 200 responses on product, COA and guide pages. Verify by IP: anyone can fake a user-agent string.

    3. Writing content an AI can cite

    AI answers quote pages that state a fact clearly and back it up. Google’s advice for its AI features is the same as for Search: helpful, reliable, people-first content, with important content available as text and structured data that matches the visible page. It also says you don’t need new machine-readable files, AI text files or special schema. For a peptide store, that points to four kinds of page.

    Pages worth building

    • Batch COA and testing pages. One page per lot with the lab’s name, test methods (for example HPLC and mass spectrometry), the date, the result as reported and a link to the original PDF. Put the key figures in HTML text, not only in a scanned image, so they can be read and quoted. Our product page template shows the layout.
    • Method and policy explainers. “How we test each batch”, “How to read a COA”, “Storage and shipping conditions”, “Who we sell to and why”. These answer the questions buyers actually ask an AI about suppliers.
    • Original data you can stand behind. For example a summary of purity results across your own published lots, with the method and date range. Only publish numbers you can support with documents.
    • Business facts. An about page with legal entity, address, contact, returns and RUO terms, matching what you publish elsewhere (section 4).

    How to write each page

    • Answer first. Put a one- or two-sentence direct answer under the heading, then the detail.
    • One topic per page, with a heading that matches the question.
    • Dates and versions. Show “last updated” and the lot or method version.
    • Name your evidence. Link the lab, the standard or the document.
    • Keep the RUO frame. No benefits, outcomes, dosing or human-use language anywhere, including FAQs. An AI quoting your page quotes your claims too. Our product risk guide explains why some compound pages need extra care.
    Same page, two audiences

    Pages that get cited in AI answers also tend to be the pages that pass ad and Merchant Center review: factual, claim-free and transparent about the business. Work on citable content supports our Google Ads for peptides and Google Shopping work rather than competing with it.

    4. Consistent brand facts everywhere

    When an AI tool describes your company, it combines what it finds about you across the web. If your name, address, founding date or testing claims differ between your site, your payment provider’s public listing, directories and social profiles, the answer may be wrong or may leave you out.

    • Write one fact sheet. Legal name, trading name, address, contact email, founding year, testing lab(s), shipping regions, return terms, RUO statement. Use it everywhere.
    • Add Organization markup to the home or about page. Google’s Organization structured data page says it helps Google understand administrative details and disambiguate your organization. It recommends the most specific subtype, such as OnlineStore, and a sameAs list of your official profiles. Markup must match the visible page.
    • Keep Merchant Center and Business Profile current. Google lists this among the SEO basics for its AI features. Our Merchant Center recovery service helps if the account is limited.
    • Clean up old profiles. Update or close abandoned social accounts, marketplace listings and directory entries with outdated details.
    • Use the same product names on your site, feed and COAs, so a batch page, a product page and a third-party mention all point to the same thing.

    5. Community participation, with disclosure

    Forums, Q&A sites and subreddits appear in AI answers, which is why sellers are tempted to plant posts there. The legitimate version is slower and works only if you are useful and open about who you are.

    • Read each community’s rules first. Many ban vendor posts, links or peptide sourcing questions outright. Respect that.
    • Post as the brand, or say you work for it. The FTC’s Endorsement Guides FAQ says employees who review or promote their company’s products should disclose the relationship. The same applies to agencies, affiliates and anyone you pay or give free product.
    • Answer method questions, not “where to buy”. Explaining how to read a COA, or what a testing method measures, is helpful. Dropping your link into sourcing threads is not.
    • Never discuss human use. If a thread is about personal use, stay out.
    • Earn independent mentions properly: share testing data with reviewers who publish their methods, sponsor with labelled disclosure, and accept that independent writers may criticise you.

    If you run affiliates, the disclosure rules in our affiliate program guide apply to their community posts as well.

    Why astroturfing backfires

    Warning: what happened on r/biohackers

    In June 2026, 404 Media reported that moderators of r/biohackers said peptide and hormone-therapy companies had been covertly spamming the subreddit so their posts would be picked up by AI chatbots. The moderators said they would ban new posts about peptides and HRT. Shopifreaks, summarising the report on 5 June 2026, described agencies using aged, human-looking accounts and paid real people to place brand mentions that read as organic.

    The result is the lesson. A community that mentioned peptides, honestly or not, closed the topic for everyone, honest suppliers included. Fake-account tactics also carry risks you can’t control:

    • Platform enforcement. Bans of accounts, links and domains, and moderators who remember brand names.
    • Legal exposure. Undisclosed paid or employee endorsements conflict with the FTC’s Endorsement Guides.
    • Answer risk. If an AI tool quotes a planted post that makes human-use claims, those claims are now attached to your brand name.
    • Payment and ad risk. Processors and ad reviewers search for your brand too. See our peptide payment processing page on why reputation matters to underwriting.

    We don’t offer seeded posts, account farms, “Reddit AEO” or undisclosed placements, and we advise clients to drop agencies that do.

    6. Tracking AI referrals and mentions

    You can’t see every AI answer that mentions you, but you can measure enough to make decisions.

    • Analytics referrals. In GA4, build an exploration or channel group for referrers such as chatgpt.com, perplexity.ai, copilot.microsoft.com and gemini.google.com. Some AI apps pass no referrer, so part of this traffic lands in “direct”. Treat the numbers as a floor. Our conversion tracking guide covers attaching orders to these sessions.
    • Google Search Console. Google says traffic from AI Overviews and AI Mode is included in the Performance report under the “Web” search type. It is not split out, so watch the queries and pages that matter.
    • Bing Webmaster Tools. The AI Performance report shows where your content is cited across Copilot, Bing and partner experiences. Microsoft added Intents, Topics, Citation Share and Compare in preview in June 2026.
    • Server logs. Count verified visits from OAI-SearchBot, PerplexityBot and Googlebot to key pages. A page that is never crawled cannot be cited.
    • A fixed prompt log. Write 15 to 25 questions buyers really ask (for example “which peptide suppliers publish batch COAs”), run them monthly in each tool and record whether you are mentioned, cited or described wrongly. Answers vary between runs, so look at trends, not single results.

    Mentions in AI answers also send buyers to your list. Capture them with clear opt-ins; our peptide email marketing service builds those flows.

    7. The 30-day checklist

    Numbered checklist
    1. Audit robots.txt against the crawler table and decide on GPTBot and Google-Extended deliberately.
    2. Check CDN, firewall and host bot settings and allow the published IP ranges for OAI-SearchBot and PerplexityBot.
    3. Confirm in server logs that search bots get 200 responses on product, COA and guide pages.
    4. Check indexing of key pages in Search Console and Bing Webmaster Tools.
    5. Publish or fix one COA page per current lot, with key results in HTML text and the original PDF linked.
    6. Write three answer-first explainers for the method and policy questions buyers ask most.
    7. Remove outcome, dosing and human-use language sitewide, including FAQs and reviews.
    8. Write the brand fact sheet and update every profile and directory to match.
    9. Add OnlineStore or Organization markup with sameAs links, matching the visible about page.
    10. Write a community and disclosure policy for staff, agencies and affiliates, and stop any undisclosed posting.
    11. Set up AI referral reporting in GA4 and verify the site in Bing Webmaster Tools.
    12. Start the monthly prompt log and repeat it on the same date each month.

    8. FAQ

    Can a peptide brand pay to be cited in ChatGPT or Google AI answers?

    Not in the organic answer. OpenAI says ChatGPT search placement is not guaranteed, and Google says indexing and serving are not guaranteed. Anyone selling guaranteed AI citations is either overpromising or manipulating a third-party source.

    Should I block GPTBot to protect my content?

    That is a business choice. OpenAI documents GPTBot as its training crawler and OAI-SearchBot as its search crawler, and the settings are independent, so you can block GPTBot and still allow OAI-SearchBot for ChatGPT search.

    Does blocking Google-Extended remove me from AI Overviews?

    No. Google says Google-Extended does not affect inclusion in Google Search, and AI Overviews and AI Mode are part of Search, controlled through Googlebot and snippet controls such as nosnippet.

    Do I need an llms.txt file or special schema for AI search?

    Google says you don’t need new machine-readable files, AI text files or special schema for its AI features. Ordinary structured data that matches the visible page, such as Organization markup, is still useful.

    What pages are most likely to be cited for a peptide store?

    Pages that answer one question clearly with evidence: batch COA and testing pages, method explainers, shipping and policy pages, and a factual about page. We cannot promise any page will be cited.

    Is it OK for my team to post about our brand on Reddit?

    Only within each community’s rules and with clear disclosure that they work for you. The FTC says employees promoting their company’s products should disclose the relationship. Many peptide communities ban vendor posts entirely.

    How do I know if AI search is sending me traffic?

    Track referrals from chatgpt.com, perplexity.ai and similar domains in analytics, review Search Console and Bing’s AI Performance report, check crawler visits in server logs, and run a fixed set of test prompts monthly.

    Want a second opinion?

    Get your peptide store ready for AI search, honestly

    Peptide Marketing works only with research-use-only peptide brands. We will check your crawler access, COA and policy pages, brand facts and tracking, and give you a prioritised fix list. We do not seed posts, run fake accounts or promise citations.

    Book a 15-min call

    Prefer email? Write to hello@peptidemarketing.info.

    Sources

    General information for businesses selling research-use-only products, not legal or regulatory advice. Sources read on 16 November 2026; platform documentation changes often.

  • Microsoft Ads for Peptides: Policy, Setup and Import From Google

    By the Peptide Marketing team, iComChain LLC · Last updated: 16 November 2026

    Microsoft Ads for peptides is the obvious second search channel once a research-use-only (RUO) store has Google Ads running. Microsoft Advertising serves ads on Bing and partner search sites, it can import your Google campaigns in a few clicks, and its policies are written differently from Google’s. This guide is for owners and marketers of RUO peptide stores. It covers Microsoft’s Healthcare and Pharmaceutical policy and where it is stricter or looser than Google’s, account setup, importing from Google Ads and what to fix afterwards, Microsoft Merchant Center, the Audience Network, UET tracking, budgets and common disapprovals. It is general information, not legal advice, and it contains no dosing, efficacy or human-use information.

    Key takeaways
    • Microsoft’s healthcare policy applies to all ad types and was last updated on 5 October 2026. Read it before you import anything.
    • Every healthcare and pharmaceutical ad must target users aged 18+. Google has no general rule like this, so imported campaigns need an age check.
    • Microsoft’s disapproved-products lists name no research peptides, but they are non-exhaustive and Microsoft can refuse any product “of questionable legality” without notice.
    • Import is a copy, not a review. Bid strategies, audiences, age groups, tracking and Display ad groups change or drop out on the way across.
    • Search campaigns include Audience ads by default. Microsoft’s own advice for opting out is website exclusions.
    • Treat Microsoft as a smaller, separate account: its own conversion goals, its own Merchant Center review and its own budget.

    1. Microsoft’s healthcare policy, compared with Google’s

    Microsoft’s Healthcare and Pharmaceutical policy says it applies to all ad types, and that Microsoft enforces the English version worldwide. The parts that matter to an RUO peptide store:

    • General requirements. Follow the law in every market you target, hold any certification or licence those markets require, and do not target consumers based on sensitive health information. The page then states: “Advertising must target users ages 18+.”
    • Disallowed products and services. Clinical trials, experimental treatments and medical research solicitations; human organs and tissue; herbal supplements that mimic illegal substances; and anything on the linked list of disapproved products.
    • Restricted claims. Health claims need credible scientific evidence, comparative claims need a named and dated third-party study, and ads and landing pages must not misrepresent regulatory approval or use unrealistic before-and-after images.
    • Prescription drugs. Online pharmacies, telemedicine providers selling prescription drugs and drug manufacturers must be preapproved through Microsoft’s program forms. Manufacturers may advertise only in Canada, New Zealand and the United States.

    The linked Disapproved Healthcare Products and Supplements page holds six non-exhaustive lists: non-pharmaceutical controlled substances, healthcare products and supplements, and products related to weight loss, sexual enhancement and bodybuilding, plus steroids. When we read it on 16 November 2026 it did not name BPC-157, TB-500, semaglutide, tirzepatide or any other research peptide we searched for. That is not a clearance. The same page says Microsoft may disallow any healthcare product “that may be of questionable legality or could potentially be harmful to users”, at any time and without prior notice.

    The honest position

    An RUO peptide store is not a pharmacy, a telemedicine provider or a drug manufacturer, so none of Microsoft’s preapproval routes is built for it. What you can control is the same as on Google: how products are named and described, that pages make no outcome or human-use claims, and that the business behind the site is transparent. Our product-by-product risk guide applies here too.

    Where Microsoft is stricter, looser or just different

    The matrix below sets the two platforms side by side. Google’s column summarises its Healthcare and medicines policy, restricted drug terms policy and personalized advertising policy.

    Topic
    Google Ads
    Microsoft Advertising
    Verdict
    Policy
    Unapproved products
    “Unapproved substances” banned regardless of claims of legality, including products subject to regulatory action or warning
    Six named-product lists plus a right to refuse anything of questionable legality
    Different wording; neither list names research peptides
    Age targeting
    No general 18+ rule that we found in the healthcare policy
    All healthcare and pharmaceutical ads must target 18+
    Microsoft stricter
    Clinical and experimental
    Speculative and experimental treatments not allowed; clinical trial recruitment allowed with limits
    Clinical trials, experimental treatments and medical research solicitations not accepted
    Microsoft stricter
    Claims
    No implied safety or efficacy for non-approved products
    Claims need evidence; comparisons need a named, dated study
    Microsoft more specific
    Pharmacies and Rx
    LegitScript plus Google certification; drug-term targeting certified in US, CA, NZ
    Preapproval by program form; manufacturers in CA, NZ, US only
    Both gated; neither route fits RUO
    Health-based targeting
    Sensitive categories lose website, YouTube and customer lists
    Must not target on sensitive health information
    Google more explicit
    Setup
    Network
    Search and Display are separate choices
    Content network ended; Search includes Audience ads
    Check exclusions
    Shopping feed
    Google Merchant Center review
    Separate store review, up to five days; domain verified first
    Two reviews, two outcomes
    Enforcement
    Own strike and suspension rules
    Three strikes per policy category; immediate suspension for egregious cases
    Separate record per platform

    Summary of policy pages read on 16 November 2026. The policy text, not this chart, is the final word.

    The useful reading of the matrix: Microsoft is not a loophole. Its lists are shorter, but its catch-all clause, its claims rules and its 18+ requirement mean a catalogue that struggles on Google will not necessarily do better on Bing. What differs is the review. Microsoft reviews ads, keywords, feeds and landing pages itself, so a product refused by Google may be approved on Microsoft or the other way round, and neither decision binds the other.

    2. Account setup and importing from Google Ads

    Setup

    • Use the same legal business name, address and domain as your site and your Google account. Consistency is what a reviewer checks.
    • Pick the account currency carefully. Microsoft’s import guide says changing currency later means setting up a new account.
    • Install the UET tag before importing (section 5), so imported conversion goals and remarketing lists have a tag to attach to.
    • Set age targeting to 18+ at the start, because the policy requires it for every healthcare and pharmaceutical ad.

    What the import does

    Microsoft’s Google import tool signs in to Google and copies the campaigns you choose, once or on a schedule. Its help page on what gets imported says not everything comes across and tells you to review campaigns afterwards. The points that matter for a peptide account:

    ItemWhat happens on importWhat to change
    Search and Display networkSearch and Display ad groups become Search; Display-only ad groups are not importedRebuild reach campaigns separately if you want them
    Performance MaxImported as Performance Max or SearchCheck which one you got and review asset groups
    Bid strategiesUnsupported strategies become enhanced CPC (manual CPC for Audience campaigns); without a Microsoft conversion goal, conversion strategies are converted, e.g. PMax to maximize clicksSet goals first, then reset strategies
    Bids and budgetsAnything below Microsoft’s minimums is raised to themSet budgets deliberately (section 6)
    Age targetingOnly age and gender import; Google’s 45-54 group is not importedRe-check age settings and confirm 18+
    AudiencesIn-market and some website visitor lists import; customer lists, affinity, YouTube and Google Analytics lists do not; memberships over 180 days drop to 180Remove lists built from product pages (section 7)
    Conversion goalsWhere available, tag-based destination-URL goals created in Google Ads import; data-driven attribution becomes last clickRebuild event goals on UET
    Negative keyword listsImported by default and merged at account, campaign and ad group levelKeep them; add Bing search terms over time
    URL trackingutm_source values such as “google” become “bing”Check templates and suffixes if managed elsewhere
    Automated rules, IP exclusionsNot importedRecreate by hand
    Scheduled imports overwrite

    Microsoft warns that re-importing can overwrite bids, budgets and settings, and can pause, rename or remove campaigns. Once you have edited the Microsoft account for policy reasons, a scheduled import can quietly undo those edits. Either stop scheduled imports, or limit them to “Items not previously imported”, once you start changing things on the Microsoft side.

    Import is also when bad copy spreads. Anything Google disapproved, and anything that only survived on Google because nobody looked, arrives in Microsoft and goes through Microsoft’s own review. Clean the source campaigns first, using the term lists in our peptide keyword guide.

    3. Microsoft Merchant Center and Shopping

    Shopping on Microsoft needs a Microsoft Merchant Center store. Microsoft’s help page says:

    • The domain must be validated first, through Bing Webmaster Tools or a UET tag. With UET, the tag must register at least 50 events before the domain appears as an option.
    • Each new store is auto-approved, auto-rejected or queued for manual review, which can take up to five days.
    • The store name appears in Product ads, so use your real trading name.

    Once the store is approved you can import offers from Google Merchant Center, manually or on a schedule, instead of keeping a second feed. To import Google Shopping campaigns you must create the Microsoft store first and link it during the import.

    Feed hygiene carries over

    A synced feed copies titles, descriptions and images exactly. If your Google feed relies on claim-free titles and plain product images, Microsoft gets the same. If it does not, fix the source: our Shopping feed guide covers titles and categories, and our Google Shopping and Merchant Center recovery services handle feeds that are already in trouble.

    4. The Audience Network: keep or exclude?

    Microsoft’s Search ads page says Search campaigns may also be extended to audience placements such as MSN, Microsoft Edge, Outlook.com and publisher partners. Its ad distribution settings page lets you choose the entire Microsoft Advertising Network or “Microsoft sites and select traffic”, and notes that all options include search and Audience ads. For opting out, Microsoft says: “we recommend using website exclusions.”

    Our default: exclude at launch

    • Policy exposure. Audience placements turn a keyword-triggered text ad into an image or native ad beside news and other content, more creative to review, more chance of a mismatch.
    • Intent. A small budget is best spent on people who searched for what you sell.
    • Measurement. Mixed search and audience traffic makes early results harder to read.

    Exclusions are managed through website control lists, which can be set at account level or attached to Search, Shopping and Audience campaigns. Run the Website URL (publisher) report every couple of weeks and add placements that are spending without converting. Once Search is profitable and tracked, test audience traffic in its own campaign rather than letting it blend in.

    5. UET tag and conversion tracking

    The Universal Event Tracking (UET) tag is Microsoft’s site tag. It records what visitors do on your site and is used for conversion goals, remarketing lists and, as above, domain validation for Merchant Center.

    • Install it sitewide directly or through Google Tag Manager, then create conversion goals for purchases and other key events.
    • Import Google goals with care. Microsoft only imports online, tag-based, destination-URL goals created in Google Ads, not Google Analytics goals, and where the option exists. Purchase events with values usually need rebuilding as UET event goals.
    • Send revenue. Without order values, value-based bidding has nothing to work with.
    • Set up consent. Microsoft’s UET Consent Mode page says visitors from the EEA, the UK and Switzerland need Consent Mode or TCF signals to avoid harm to conversion attribution and remarketing. It lists supported consent platforms and leaves legal compliance to you.
    Keep events neutral

    Microsoft’s healthcare policy bars targeting based on sensitive health information. Name events and goals after actions (“purchase”, “add to cart”), not compounds, and do not build remarketing lists from individual product pages. Our conversion tracking guide covers server-side and deduplication, and our remarketing guide explains why owned email lists do more of the follow-up work.

    6. Budgets and bidding for a smaller channel

    Microsoft’s minimums are low. Its import guide lists a USD 0.05 minimum daily budget for Search and Shopping campaigns and minimum bids of USD 0.05 for Search and USD 0.01 for Shopping. The real constraint is volume: fewer searches mean fewer conversions, so automated bidding takes longer to learn.

    1. Start with what already works. Import only your best Google campaigns, usually brand and the strongest generic Search ad groups.
    2. Use manual or enhanced CPC at first until each campaign has a steady flow of tracked conversions, then test Maximize conversions or target CPA.
    3. Size the budget to the test. Set a daily budget that can buy enough clicks to reach a decision within a few weeks, and a fixed test length.
    4. Review search terms weekly. Search terms on Bing will not match Google’s exactly; feed new negatives into your shared lists.
    5. Judge Microsoft on its own numbers. Compare cost per order and refund rates per platform, not blended totals.
    6. Scale when the numbers hold. Raise budgets in steps and watch cost per order after each step.

    Our Google Ads for peptides service runs Microsoft accounts the same way: one clean source account, a controlled import, and separate reporting.

    7. Common disapprovals and the launch checklist

    Microsoft’s enforcement page describes three levels: disapproval of an ad or component (including product feeds, landing pages, keywords and settings), strikes, and immediate suspension. An advertiser gets up to three strikes within a policy category before the account is suspended. Egregious violations are suspended at once, without warning.

    The disapprovals we expect on a peptide account

    • Healthcare and pharmaceutical. Compound names that match prescription drugs, or landing pages that read as treatment content.
    • Restricted claims. Outcome words, unsupported superlatives, or wording that suggests regulatory approval.
    • Disallowed products. Items in or near the steroid, weight-loss or bodybuilding lists.
    • Experimental or research solicitation. Copy that reads as recruiting people into research rather than selling lab supplies.
    • Age targeting. Healthcare ads not limited to 18+.

    If you think a decision is wrong, Microsoft’s disapproval help page lets you request an exception. Most reviews finish within 48 hours, and if a component is disapproved a second time, the decision is final. So fix first and appeal only when the ad is clean. Each strike counts, and repeated exceptions on content that does break policy add up. If an account is suspended, the approach in our Google suspension guide transfers: one honest, documented appeal.

    Launch checklist
    1. Read the Healthcare and Pharmaceutical policy and the disapproved-products lists, and note the date you read them.
    2. Clean the Google source campaigns: claim-free ads, safe keywords, current negative lists.
    3. Create the account with matching business details and the right currency.
    4. Install UET sitewide, with Consent Mode for EEA, UK and Swiss visitors.
    5. Create purchase conversion goals with revenue before importing.
    6. Import selected Search campaigns, not the whole account.
    7. Set 18+ age targeting and check every imported age setting.
    8. Reset bid strategies and budgets on purpose.
    9. Remove product-page remarketing lists and any customer-list logic.
    10. Add website exclusions for Audience placements.
    11. Validate the domain and create the Merchant Center store if you plan Shopping.
    12. Switch off or narrow scheduled imports after the first edit.
    13. Check disapprovals daily for the first two weeks and fix disapprovals before requesting exceptions.

    8. FAQ

    Can I advertise peptides on Microsoft Ads?

    Microsoft does not publish a peptide-specific rule. Its Healthcare and Pharmaceutical policy applies to every ad, its disapproved-products lists did not name research peptides when we read them, and it can refuse any product of questionable legality. Ads must be claim-free and target users aged 18 and over.

    Is Microsoft Advertising looser than Google Ads for peptide stores?

    Not overall. Its product lists are shorter, but it requires 18+ targeting for all healthcare ads, bans experimental treatment and research solicitation content, and has detailed claims rules. Reviews are independent, so results can differ product by product.

    Should I import my Google Ads campaigns into Microsoft?

    Yes, if the Google campaigns are clean. Import selected Search campaigns, then reset bid strategies, budgets, age targeting, audiences and tracking, and stop scheduled imports once you edit the Microsoft side.

    Does Microsoft Shopping use my Google Merchant Center feed?

    It can. After you create and get approval for a Microsoft Merchant Center store, you can import offers from Google Merchant Center manually or on a schedule. Microsoft reviews the products itself.

    Should I exclude the Microsoft Audience Network?

    We exclude it at launch for peptide accounts. Search campaigns can serve Audience ads, and Microsoft’s recommended way to opt out is website exclusions. Test audience traffic separately once Search is tracked and profitable.

    Do I need the UET tag?

    Yes. UET powers conversion goals and remarketing lists, and it is one of two ways to validate your domain for Merchant Center. For visitors from the EEA, the UK and Switzerland, Microsoft asks for Consent Mode or TCF signals.

    What happens if Microsoft disapproves my ads?

    You can fix the ad or request an exception. Most reviews take up to 48 hours, a second disapproval is final, and repeated violations in one policy category can lead to suspension after three strikes.

    Want a second opinion?

    Launch Microsoft Ads without importing your Google problems

    Peptide Marketing works only with research-use-only peptide brands. We will review your Google account before import, set up UET and Merchant Center, and run the first weeks of Microsoft Ads with clean reporting. We do not help work around platform policies. For payment set-up behind the ads, see our peptide payment processing service, and for follow-up, our peptide email marketing service.

    Book a 15-min call

    Prefer email? Write to hello@peptidemarketing.info.

    Sources

    General information for businesses selling research-use-only products, not legal or regulatory advice. Sources read on 16 November 2026; policies change.

  • Remarketing for Peptide Brands: Audiences, Limits and What Still Works

    By the Peptide Marketing team, iComChain LLC · Last updated: 16 November 2026

    Peptide remarketing is harder than remarketing for an ordinary online store. If Google treats your ads or site as health-related or as promoting prescription drug terms, its personalized advertising policy stops you using your own audience lists, and Meta can restrict the data your pixel sends. This guide is for owners and marketers of research-use-only (RUO) peptide stores. It explains which audience types are affected on Google and Meta, how Customer Match eligibility works, what Performance Max does with audience signals, why email and SMS carry most of the load, and how to tell whether remarketing adds sales at all. It is general information, not legal advice, and it contains no dosing, efficacy or human-use information.

    Key takeaways
    • Google’s rule is about what you promote. Advertisers promoting in a sensitive interest category, including Health and Restricted drug terms, cannot use advertiser-curated audiences such as website visitors, Customer Match or lookalikes.
    • Google’s own audiences stay open. Predefined audiences such as affinity and in-market segments can still be used, because Google excludes sensitive signals from them.
    • Customer Match has its own gate. Full targeting needs good compliance and payment history, 90 days of account history and more than USD 50,000 lifetime spend.
    • Meta restricts the data, not just the ad. A health and wellness data source category can limit lower-funnel events, and flagged custom audiences cannot be used.
    • Owned channels do the real remarketing. Consented email and SMS lists are yours, and they are where most follow-up should happen.
    • Measure lift, not attributed sales. Remarketing audiences buy anyway at high rates; only a holdout test shows what the ads added.

    1. Google’s personalized advertising policy

    Google’s Restricted targeting in Personalized advertising policy lists sensitive interest categories. Two matter most for peptide stores:

    • Health. This covers physical or mental health conditions, products to treat or manage chronic conditions, and invasive procedures, with injections named as an example.
    • Restricted drug terms. This covers prescription medications and information about them. Content aimed at healthcare professionals is excluded in the US, Canada and New Zealand, but only for advertisers who hold the separate personalization certification.

    The consequence is the same for both: “Advertisers promoting products and services that fall within sensitive interest categories are unable to use advertiser-curated audiences.” Predefined Google audiences remain available, because Google says sensitive user signals are excluded from them. Users under 18 receive no personalized ads of any kind.

    Google also does not let you use a negative list as a back door. The policy says advertisers “must not use negative remarketing lists for positive personalization”, and it bans data segments that target an overly narrow audience, including when combined with tight location targeting.

    Does this apply to an RUO store?

    Google classifies ads and destinations, not business models, and the research-use label does not decide it. A compound that shares a name with an approved drug’s active ingredient is a prescription drug term. Pages that read as treatment, injection or condition content fit the Health description. Our working assumption is that remarketing lists may be restricted at any time, so we plan campaigns that still work without them. If ads are flagged, Google’s first listed fix is to remove the advertiser-curated audiences, and that is the fix to use.

    The policy applies on top of everything else. Google’s Healthcare and medicines policy still decides whether a product may be advertised at all. Our guide on which peptides can be advertised covers that first step.

    2. Which audience types are affected

    Google now calls remarketing “your data”. Its your data segments page lists website visitors, dynamic remarketing, data segments for Search ads, YouTube users, Customer Match, app users and lead form segments. All of these are advertiser-curated, so all of them are affected if you promote in a sensitive category.

    Broad reachGoogle affinity, in-market, life events, demographics, location
    AllowedPredefined Google audiences, even in sensitive categories
    WatchCustom segments with sensitive ads or pages serve only on Display, to non-sensitive audiences or contextually
    EngagedWebsite visitors, YouTube viewers, Meta engagement audiences
    RestrictedAdvertiser-curated on Google if you promote in Health or Restricted drug terms
    RestrictedMeta may limit events and flag audiences for health data sources
    High intentCart and checkout visitors, past buyers, Customer Match, lookalikes
    RestrictedCustomer Match also needs eligibility and bars pharmaceutical promotion
    RestrictedMeta lower-funnel events can be blocked, shrinking these lists
    Owned listsConsented email and SMS subscribers
    UsableYour list, your rules, subject to consent law and sender policies
    UsableHold out a group to measure what follow-up adds

    Shaded cells are restricted when your ads or site fall in a sensitive category. Policy text, not this chart, is the final word.

    Audience typeGoogle, sensitive categoryMeta, restricted data sourceWhat we do
    Website visitorsNot allowed (your data segment)Website custom audiences depend on events Meta may limitUse only if ads are not in a sensitive category; remove if flagged
    YouTube viewersNot allowed (your data segment)Video engagement audiences must not reflect health informationUse YouTube for reach with predefined audiences
    Customer listsNot allowed; Customer Match also has eligibility rulesFlagged if the list or its name implies health informationKeep lists neutral; rely on email and SMS instead
    Lookalikes or similarNot allowedFlagged if the seed audience is flaggedBuild from neutral seeds only, where permitted
    Affinity and in-marketAllowedDetailed targeting on health causes was removed in 2022Use broad, interest-neutral targeting
    Email and SMSNot an ad audienceNot an ad audienceMain remarketing channel

    Google notes that Demand Gen campaigns use advertiser-curated audiences by default and may be restricted from serving in sensitive categories. Check those first if impressions drop.

    What still works without your lists
    • Brand Search. Returning visitors often search your brand name. A brand campaign catches them without any audience list.
    • Search and Shopping for lower-risk products. Keyword intent does the job that a remarketing list would otherwise do.
    • Predefined Google audiences on YouTube and Display, used for reach rather than follow-up.
    • Owned lists. Email and SMS, covered in section 6.

    None of these needs a workaround, and none breaks if Google later reclassifies your ads.

    3. Customer Match eligibility

    Customer Match has its own policy, separate from the sensitive-category rules. Access depends on the account:

    • Every account needs a good history of policy compliance and a good payment history. Without both, the account is ineligible.
    • All policy-compliant accounts can use Customer Match in the Observation setting and for exclusions.
    • Accounts with 90 days of history and more than USD 50,000 lifetime spend can also use the Targeting setting and manual bid adjustments.

    Other rules worth knowing:

    • Upload only data you collected first-party, and say in your privacy policy that you share customer data with service providers.
    • List memberships expire after 540 days, and a list needs at least 100 members added or updated in that window to stay eligible.
    • The policy does not allow ad content that implies knowledge of a customer’s sensitive information, or promotion of “products related to sensitive information, such as pharmaceutical products” in a Customer Match campaign.
    • Google says it may remove access for any advertiser, and an account with a suspension or repeated disapprovals should not expect it. Our suspension recovery guide covers rebuilding that history.
    Exclusions

    The Customer Match policy lists exclusions as available to all compliant accounts, and excluding existing buyers from prospecting is a common use. The personalized advertising policy does not say whether exclusions count as using an advertiser-curated audience in a sensitive category. If an excluded list triggers a flag, remove it rather than appeal.

    4. Meta’s limits on health-related audiences

    Meta works on the data side. Its data source categories page says websites and apps may be assigned a category such as “Health and wellness”, and that some categories carry extra data sharing restrictions. Its page on restrictions by data source category lists three levels:

    1. Core setup. Custom parameters and the parts of URLs after the domain are not shared.
    2. Restriction on certain standard events. Specific mid- and lower-funnel events are blocked.
    3. Full restrictions. No events are shared in some or all regions, and Meta Business Tools cannot be used for ads purposes there.

    For remarketing, the second and third levels matter most. If add-to-cart or purchase events cannot be shared, audiences built from them stop filling. Meta suggests upper-funnel events, or objectives that do not rely on shared data such as Awareness, Engagement and Traffic.

    Audiences are policed separately. Meta’s page on restrictions on certain custom audiences says custom or lookalike audiences that include information not allowed under its terms, such as references to specific health conditions, are flagged and cannot be used. Its prohibited information page adds that audience names and criteria must not reflect or imply such information.

    On targeting, Meta removed Detailed Targeting options relating to sensitive topics, including health causes, from 19 January 2022. Whether a peptide product can be advertised on Meta at all is decided by its Drugs and Pharmaceuticals standard, which you should read before any spend.

    What not to do

    Do not choose a data source category you know is wrong, rename events to hide what they track, or send purchase data under a neutral event name. Meta says you can categorise your own data sources, but it can also assign a category you cannot change, and it treats prohibited information as a breach of its Business Tools Terms. If you think a category is wrong, use the review request in Events Manager.

    5. Remarketing inside Performance Max

    Performance Max has no separate remarketing switch. Google’s audience signals page lists website visitor lists, customer lists and video viewer lists as inputs, alongside custom segments and Google’s own segments. Two points follow:

    • Signals are suggestions. Google says Performance Max may show ads to audiences outside your signals, so a signal never limits who sees an ad.
    • Your data signals are advertiser-curated. If the campaign promotes in a sensitive category, Google’s fix is to remove them from asset groups as well as campaigns and ad groups.

    A peptide Performance Max campaign should still work with signals built only from search-term custom segments and predefined Google audiences. Keep product feeds limited to items you are prepared to defend. Our Performance Max guide covers the setup, and our Google Ads and Google Shopping services build campaigns this way. Feed problems belong with Merchant Center recovery.

    6. Owned-channel remarketing: email and SMS

    A consented list is the one remarketing audience no ad platform can switch off. It is also where most follow-up with a peptide customer should happen.

    Email

    • Build the list at checkout and with a sign-up form, with clear consent wording.
    • Automate the basics: order confirmation and shipping, a browse or cart reminder, a restock alert and a periodic catalog update.
    • Follow CAN-SPAM. The FTC’s compliance guide requires a valid physical postal address, a clear way to opt out, and honouring opt-outs within 10 business days.
    • Keep content RUO. Emails are advertising matter. Use product names, specifications, lot and certificate links, and no outcome claims.
    • Check your sending platform’s acceptable use policy before you import a list.

    SMS

    SMS needs explicit consent, carrier registration and a platform that accepts the category, and several do not. Our SMS marketing guide covers platform policies and what to send. Keep SMS to transactional updates and occasional offers.

    Our peptide email marketing service sets up these flows, and product pages built from our product page template give every email a claim-free destination.

    7. Frequency and creative rules

    Frequency

    Google’s frequency capping works in Display and Video campaigns. Display caps are set after the campaign is created, under Frequency management, and count only viewable impressions. Video caps are set at campaign level by impressions, views or both, per day, week or month. Frequency capping is not supported in Demand Gen. Start with a modest weekly cap and raise it only if a lift test supports it.

    Creative

    • Do not imply you know who the viewer is or why they visited. The Customer Match policy bars ads that imply knowledge of sensitive information, and “still thinking about it?” copy naming a compound comes close.
    • Use brand and catalog messages: lab standards, certificates of analysis, shipping, support.
    • Keep the same claim-free standard as your product pages. No outcomes, conditions, dosing, before-and-after imagery or syringes.
    • Check dynamic remarketing feeds. Dynamic ads pull titles and images straight from the feed, so a risky product in the feed becomes a risky ad.

    8. Measuring incrementality

    Remarketing audiences are people who were already interested, so platform-attributed conversions overstate what the ads caused. Lift testing compares people who could see the ads with people who could not.

    • Google Conversion Lift. Google’s Conversion Lift splits users or geographies into treatment and control groups and reports incremental conversions, incremental cost per action and incremental ROAS. It is not available to every account; you request it through a Google representative.
    • Geo holdouts. Pause a campaign in comparable regions for a fixed period and compare sales against regions where it ran.
    • Email and SMS holdouts. Keep a random share of subscribers out of a flow and compare their order rate with those who received it.

    Reading the result

    • Lift close to zero means the audience would have bought anyway. Move the budget to prospecting or cut it.
    • Positive lift with a high incremental cost per action means the ads help but cost too much. Lower the frequency cap or narrow the window before you scale.
    • Inconclusive results usually mean too few conversions. Run the test longer or test a bigger share of spend, rather than reading noise as a result.

    Decide the test length, success metric and holdout size before the test starts, and do not stop early on a good week. Clean conversion data matters here; our conversion tracking guide covers GA4, enhanced conversions and server-side setups. Count refunds and chargebacks against the result too; if a processor switch has broken your order data, our peptide payment processing service can help steady it first.

    9. The remarketing setup checklist

    Run before launch, then quarterly
    1. Read the Health and Restricted drug terms pages and record whether your ads and destinations plausibly fall in either.
    2. Check Policy manager for personalized advertising flags on ads, asset groups and campaigns.
    3. Remove advertiser-curated audiences from any flagged campaign, ad group and asset group.
    4. Check Customer Match eligibility: compliance history, payment history, 90 days and USD 50,000 lifetime spend.
    5. Review Demand Gen campaigns, which default to advertiser-curated audiences.
    6. Open Meta Events Manager and record your data source category and any event restrictions.
    7. Rename audiences and events so none reflects a health condition or other prohibited information.
    8. Rebuild Performance Max signals from custom segments and predefined audiences only if needed.
    9. Set frequency caps on Display and Video campaigns.
    10. Audit remarketing creative and feeds for outcome words, compound-specific follow-up copy and product imagery.
    11. Confirm email and SMS consent, opt-out handling and postal address.
    12. Schedule a holdout test before increasing any remarketing budget.

    10. FAQ

    Can a peptide store run remarketing on Google Ads?

    Only if its ads and destinations do not fall in a sensitive interest category such as Health or Restricted drug terms. If they do, Google does not allow advertiser-curated audiences, which include website visitors, YouTube users and Customer Match lists.

    Which Google audiences can I still use?

    Predefined Google audiences such as affinity, in-market, life events and demographics, plus location targeting. Google says sensitive user signals are excluded from them, so they stay available in sensitive categories.

    Am I eligible for Customer Match?

    You need a good policy compliance and payment history. Observation and exclusions are open to compliant accounts; targeting and bid adjustments need 90 days of history and more than USD 50,000 lifetime spend.

    Why did my Meta retargeting audiences shrink?

    If Meta assigned your website a health and wellness data source category, it may block mid- and lower-funnel events, so audiences built on them stop filling. Check the category in Events Manager and request a review if it is wrong.

    Does Performance Max remarket automatically?

    Performance Max can use your data as audience signals, but signals are suggestions and Google may show ads beyond them. In a sensitive category, remove your data signals and rely on custom segments and Google’s own audiences.

    Is email a workaround to these policies?

    No, it is a separate channel with its own rules. A consented list you own is not an ad audience, but CAN-SPAM, consent law and your sending platform’s policies apply, and emails must stay claim-free.

    How do I know if remarketing is working?

    Run a lift test. Use Google Conversion Lift if your account has it, or a geo or list holdout, and compare treated and control groups rather than trusting attributed conversions.

    Want a second opinion?

    Check your remarketing setup before it gets flagged

    Peptide Marketing works only with research-use-only peptide brands. We will review your audiences, Performance Max signals, Meta data setup and email flows, and tell you what to keep, what to remove and how to test the rest. We do not help work around platform policies.

    Book a 15-min call

    Prefer email? Write to hello@peptidemarketing.info.

    Sources

    General information for businesses selling research-use-only products, not legal or regulatory advice. Sources read on 16 November 2026; policies change.

  • Sales and Promotions for Peptide Stores: A Year-Round Calendar

    By the Peptide Marketing team, iComChain LLC · Last updated: 16 November 2026

    Peptide sale promotions work best as a planned year, not a scramble every November. This guide is for owners and marketers of research-use-only (RUO) peptide stores. It gives you a 12-month promotions calendar, the promotion types worth running, how to keep a sale price identical across your site, your Merchant Center feed and your ads, and the email, SMS and ad-copy rules that keep a sale from turning into a policy problem. It contains no dosing, efficacy or human-use information, and it is general information, not legal advice.

    Key takeaways
    • Plan four to six real events a year and leave quiet months quiet. A store that is always on sale has no believable regular price.
    • Anchor the calendar to the lab year: budgets, terms and restocks, not resolutions or summer bodies.
    • One price, everywhere. Google says your sale_price must match the landing page and checkout. Change site, feed and ads together.
    • Pick one Google mechanism per discount. A visible sale price goes in sale_price; a code-based offer can be a Merchant Center promotion. Google does not accept a promotion for a discount the page already shows.
    • Former prices must be real. FTC pricing guides expect a reference price that was openly offered for a reasonably substantial period.
    • Promotions raise the stakes on copy. Urgency is fine; outcome, body or health angles are not.

    1. Why a calendar beats ad-hoc discounting

    Most peptide stores discount reactively: a slow week, a competitor’s code, a pile of stock near its retest date. The result is a regular price nobody pays and a list that only opens emails with a percentage in the subject line. A calendar fixes three things.

    • Price credibility. The FTC’s Guides Against Deceptive Pricing (16 CFR 233.1) treat a former price as genuine only if it was offered to the public openly, in good faith, for a reasonably substantial period. Google’s sale price annotation rules apply a similar logic to the strikethrough price, and note that a sale should ideally not run beyond 30 days.
    • Review lead time. Merchant Center promotions should be submitted at least 24 hours before they start, and review can take up to 72 hours. Last-minute sales miss the Shopping side.
    • Compliance review. Every sale creates new ad text, banners, emails and texts. Planning ahead gives someone time to read them all before they go out.
    Who you are selling to

    An RUO store’s legitimate buyers are labs, research groups and procurement staff. Promotions should speak to their calendar: grant and fiscal-year spending, new terms and projects, restocking and documentation. If a promotion only makes sense to someone using the product on themselves, it does not belong on an RUO store.

    2. The 12-month promotions calendar

    The grid below is a working template. Black cells are the peak events most stores will run; white cells are lighter touches or deliberate rest months. Swap months to fit your buyers’ terms and fiscal years.

    Peak event   Light touch or rest

    JanuaryNew-year restock: refresh the lab’s standing order, quantity breaks on core SKUs.Quantity breaks
    FebruaryRest month. Fix pages, COAs and feed errors found in January.No discount
    MarchSpring catalog update: launch new lots or SKUs with documentation.New-product bundle
    AprilSpring sale: a short, dated sitewide or category offer.Discount code
    MayLoyalty month: thank repeat accounts with a private code.Loyalty offer
    JuneMid-year and fiscal year-end: free-shipping threshold for consolidated orders.Free shipping
    JulyRest month. Review results, plan autumn creative.No discount
    AugustBack-to-lab season: new terms and projects, starter bundles of core supplies.Bundles
    SeptemberRestock reminders for accounts that bought in August.Restock offer
    OctoberPrepare Black Friday: submit promotions, set feed dates, pre-write emails.Prep only
    NovemberBlack Friday and Cyber Monday as one dated event.Discount code + sale_price
    DecemberYear-end: budget-use-it orders, then a quiet holiday close.Quantity breaks

    Five peak events and seven lighter months. No month is built around a personal or body-related angle.

    New Year (January)

    The new-year angle for an RUO store is the restock, not the resolution. Frame it as setting up the year’s standing order: quantity breaks on the compounds a lab orders repeatedly, and reminders about lead times. Google Ads includes New Year’s among the occasions for promotion assets, so you can label the offer without inventing a hook.

    Spring (March to May)

    Spring works well for one short, clearly dated sale and for introducing new lots or SKUs. Google Ads lists Spring Sale as an occasion with no fixed date range. Keep the sale to a week or two so the regular price stays the regular price.

    Mid-year (June)

    Many institutions close their fiscal year mid-year. Check when your own buyers’ year ends rather than assuming. A free-shipping threshold suits this window because it encourages one consolidated order instead of a discount on each item.

    Academic and back-to-lab season (August and September)

    New terms bring new projects and new people ordering. Starter bundles of core research supplies, clear documentation and fast shipping matter more than a deep discount. Back to school is a promotion-asset occasion with no fixed dates, though “back to lab” in your own copy is more accurate for your audience.

    Black Friday and Cyber Monday (November)

    Treat these as one event with one start and one end. The Google Ads occasion runs from 15 October to 15 December, and occasion-specific assets must be created or edited within six months of the occasion or they stop serving. Do the work in October: submit Merchant Center promotions, set sale_price_effective_date in the feed, and write every email before the week starts. Our Performance Max guide covers asset groups if you run a seasonal one.

    Year-end (December)

    Some buyers have budget to spend before the year closes; others are away. A short quantity-break offer early in the month, followed by clear holiday shipping cut-offs, is usually enough. End the year with no active sale so January’s prices are clean.

    3. Promotion types and when to use each

    Each promotion type changes buyer behaviour differently. Choose by the goal, not by habit.

    TypeBest forHow Google handles itWatch out for
    Discount codeDated events, email and SMS lists, affiliatesCan be a Merchant Center promotion (generic code). Minimum 5% or $5 off.Codes leaking to coupon sites; code must work at checkout
    Visible sale priceSitewide or category salesSubmit sale_price plus effective dates. Not a promotion.Must match page and checkout; avoid permanent “sales”
    BundleBack-to-lab starters, new launchesA separate product with its own price in the feedNever bundle compounds with reconstitution supplies or use “kit” framing
    Quantity breakRestocks, standing ordersTiered discounts are a permitted promotion typeKeep tiers simple and shown on the product page
    Free-shipping thresholdRaising order value, fiscal year-endShipping promotions need a redemption code unless combined with another permitted promotionFeed shipping settings must match the site
    Restock offerAccounts that ordered 30 to 90 days agoUsually email-only; no feed changeBase it on order history, not on assumed use
    Loyalty offerRepeat accountsLoyalty promotions are permitted if membership is free; member prices use loyalty_program, not sale_priceRestricted-audience promotions can be disapproved

    Restock and loyalty offers

    Restock and loyalty offers are the quietest promotions on the calendar and often the most useful. They go to accounts that already know your documentation and shipping, so they need less persuasion and less discount. Build the restock trigger from order history: a reminder at a set interval after the last order of a SKU, with the lot and COA information the buyer will need. Do not write it as if you know how the product was used, and do not time it to a supposed usage cycle. A loyalty offer can be as simple as a private code for accounts with several past orders, sent by email with a clear end date. Keep loyalty codes out of public channels, and rotate them so a leaked code does not become a permanent discount.

    The bundle trap

    FDA’s 2026 warning letters to peptide sellers, such as the Royal Peptides letter, cited multi-compound kits and bacteriostatic water sold alongside peptides. A “starter bundle” that looks like a kit for preparation and use raises your risk on every platform. Bundle research supplies and documentation, not a ready-to-use set. Our product risk guide explains why.

    4. Keeping prices consistent: site, feed and ads

    Price mismatches are one of the easiest ways to lose Shopping listings during a sale. Google’s sale_price page says to submit a value that matches the sale price on your landing page and at checkout, and to keep the full regular price in price. Both prices must be clearly shown on the landing page.

    Sale price in the feed

    • Submit both attributes. Use sale_price with sale_price_effective_date, an ISO 8601 range such as 2026-11-27T00:00-0500/2026-12-01T23:59-0500. Without a time zone Google uses UTC. In online inventory update feeds the two attributes must be provided together.
    • Schedule, do not hand-edit. Effective dates let the feed switch on and off with the site, so you are not racing to update at midnight.
    • Strikethrough eligibility. For US Shopping ads, Google’s annotation rules require the base price to have been charged for 5 days in the past 30 or 15 days in the past 200, with a discount between 5% and 90%. Annotations are not guaranteed even when you qualify.

    Merchant Center promotions

    Promotions show an offer such as a code alongside eligible listings. Per Google’s Promotions guide and data specification:

    • Discounts must be at least 5% or $5 off; vague “up to” offers are not allowed, and promotions cannot run longer than six months.
    • A promotion must be redeemable at checkout, and the promotion page must match the submitted details.
    • Google does not accept a promotion for a discount already reflected on the product page. A visible sale belongs in sale_price.
    • Promotions limited to a subset of shoppers can be disapproved.

    A promotion can only appear next to listings that are already approved. If products are disapproved under healthcare policies, fix that first; see our feed optimization guide and Merchant Center recovery service.

    Ads and promotion assets

    Google’s promotion asset requirements point to the unavailable offers policy: prices and offers in ads must be accurate and easy to find on the destination. Set the asset’s dates to match the sale, and remove sale headlines from responsive search ads when the event ends.

    The one-sheet rule

    Keep one sheet per promotion with the regular price, sale price, code, start and end times with time zone, and the product IDs included. Site, feed, ads, email and SMS are all built from that sheet, so there is only one version of the truth.

    5. Email and SMS sequences around a sale

    Owned channels carry most of a peptide store’s promotions because paid reach is limited. A simple sequence for a dated event:

    TimingEmailSMS (opted-in subscribers only)
    3 to 5 days beforeAnnouncement: dates, what is included, shipping cut-offsNone
    Start dayLaunch with code or sale linkOne short launch message with brand name and opt-out
    MidpointCategory focus or restock reminder for past buyersNone
    Final 24 hoursLast-call with exact end time and time zoneOne reminder, if your platform and consent allow it
    AfterThank-you and order-status information; no extension unless pre-announcedNone

    Under the FTC’s CAN-SPAM compliance guide, promotional email needs a subject line that reflects the content, a clear identification as an advertisement, a valid physical postal address, and a working opt-out honoured within 10 business days. A “last chance” email that is not the last chance is a deceptive subject line.

    SMS has stricter platform and carrier rules, and some SMS providers do not accept peptide content at all. Read our peptide SMS marketing guide before you add texts to a sale. Our peptide email marketing service builds these sequences, and if affiliates share your codes, the disclosure rules in our affiliate program guide apply.

    6. Ad-copy rules for promotions

    A sale tempts copywriters to reach for the angles that consumer health brands use. On an RUO store those angles create exactly the evidence regulators and ad reviewers look for, because 21 CFR 201.128 lets intended use be shown by advertising matter.

    AvoidUse instead
    “New year, new body” or any resolution, weight or fitness hook“Set up your 2027 lab order: quantity pricing on core SKUs”
    “Summer-ready”, “recovery season”, “glow-up sale”“Mid-year restock: free shipping over a set order value”
    Compound name next to an outcome or conditionCompound name, purity, COA and “for laboratory research use only”
    Images of syringes, people or before-and-after visuals in sale bannersBrand graphics, dates and the offer itself
    “Up to 70% off” with no floor“20% off all research peptides, 27 Nov to 1 Dec”
    Fake countdown timers that resetA real end time stated in the ad and on the page
    “Was $X” for a price you rarely chargedA reference price you actually sold at for a substantial period

    Do not use a promotion to reintroduce products or terms you have kept out of your ads. Sale campaigns should use the same product exclusions, negative keywords and risk tiers as your regular campaigns; our keyword guide and RUO website compliance checklist cover what to keep out. Our Google Ads for peptides and Google Shopping for peptides services follow these rules.

    Payments during a sale

    A sale can lift order volume quickly. Tell your processor before a large event so the spike is expected, and watch disputes in the following weeks. Our chargebacks guide and peptide payment processing service cover this.

    7. The pre-launch promotion checklist

    Run this for every sale
    1. Fill in the one-sheet: regular price, sale price or code, product IDs, start and end with time zone.
    2. Confirm the reference price is genuine and has been charged openly for a substantial period.
    3. Exclude high-risk products and anything kept out of your regular campaigns.
    4. Set the site sale or code and test it at checkout on desktop and phone.
    5. Add sale_price and sale_price_effective_date to the feed, or submit a Merchant Center promotion, never both for the same discount.
    6. Submit promotions at least 24 hours ahead, allowing up to 72 hours for review.
    7. Create or edit promotion assets with matching dates, and prepare sale headlines to pause on the end date.
    8. Read every ad, banner, email and text for outcome, body or human-use wording.
    9. Check email compliance: honest subject lines, postal address, working opt-out.
    10. Confirm SMS consent and platform rules before any text goes out.
    11. Tell your processor about expected volume.
    12. After the end time, confirm site, feed and ads have all returned to regular prices, and log the result.

    Measuring a promotion

    Judge each event on margin and repeat orders, not on revenue alone. Before the sale, write down the baseline for the same period without a discount; after it, compare orders, average order value, discount cost and how many new accounts ordered again within the following months. If a promotion mostly pulled forward orders that would have come anyway, run it shorter or with a smaller discount next year. Make sure purchases with and without codes are tracked separately so you can tell the difference. Our conversion tracking guide covers how to pass order values and discounts into GA4 and Google Ads. Keep the one-sheets and results together; by the second year they become your own calendar, built from your buyers rather than from a template.

    8. FAQ

    How many peptide sale promotions should a store run each year?

    We suggest four to six planned events with quiet months between them. Fewer, dated events keep your regular price believable and give you time to review copy and feed changes.

    Should I use sale_price or a Merchant Center promotion?

    Use sale_price when the discounted price is shown on the product page. Use a promotion for a code or offer applied at checkout. Google does not accept a promotion for a discount the page already displays.

    Why did my sale price not show a strikethrough in Shopping?

    Google only shows sale price annotations when the base price has history, the discount is between 5% and 90%, and both prices appear on the page. Even then, annotations are not guaranteed.

    Can Merchant Center promotions show on disapproved products?

    No. A promotion appears alongside listings that are already serving. Fix product disapprovals first.

    Is a new year promotion safe for an RUO store?

    Yes, if it is about the lab’s new-year restock and pricing. Avoid resolution, weight or body messaging, which suggests human use.

    Can I bundle peptides for a back-to-lab sale?

    Bundle research supplies and documentation, but do not bundle compounds with reconstitution supplies or present a ready-to-use kit. FDA’s 2026 warning letters cited both.

    Can I extend a sale that is performing well?

    Only if you update the site, feed, promotion and ads together and your messaging did not promise a firm end. Repeated extensions undermine ‘last chance’ claims and your reference price.

    Plan your year

    Get a promotions calendar built for your store

    Peptide Marketing works only with research-use-only peptide brands. We will map your year of sales, set up feed sale prices and promotions, and review every ad and email before it goes out. We do not help disguise products or work around platform policies.

    Book a 15-min call

    Prefer email? Write to hello@peptidemarketing.info.

    Sources

    General information for businesses selling research-use-only products, not legal or regulatory advice. Sources read on 16 November 2026; policies change.

  • Which Peptides Can You Advertise? A Product-by-Product Risk Guide

    By the Peptide Marketing team, iComChain LLC · Last updated: 16 November 2026

    Which peptides can be advertised? For a research-use-only (RUO) store the honest answer is that no compound is pre-approved for ads, and some carry far more risk than others. Google, Meta, Microsoft and payment processors judge each product by its name, how it is presented and what regulators have said about it. This guide is for owners and marketers of RUO peptide stores. It shows how to sort a catalog into three risk tiers, why compounds that match approved drug ingredients sit at the top, what the FDA has said in 2026, and how to structure campaigns so one product does not put the whole account at risk. It is general information, not legal advice, and it contains no dosing, efficacy or human-use information.

    Key takeaways
    • Risk is set per product, but enforcement lands on the account. One high-risk listing can produce strikes that affect every campaign.
    • Highest risk: compounds that share a name with an approved drug’s active ingredient, such as semaglutide and tirzepatide, and the GLP-1 compounds FDA has named in its 2026 warnings.
    • Elevated risk: compounds FDA has written about in its compounding safety lists or reviewed at its July 2026 advisory committee, plus blends, kits and anything sold beside reconstitution supplies.
    • Lower risk is relative. It means fewer triggers, not approval. Google’s unapproved substances policy still applies.
    • Names and pages move products between tiers. Outcome claims raise the tier. Disguised names are a separate violation.
    • Structure is about clean data, not hiding. Advertise only what you are prepared to defend, and disclose the whole catalog to your processor.

    1. Why the answer depends on the product

    Ad platforms do not publish a list of peptides you may advertise. They publish rules about categories of product and presentation, and they apply them product by product.

    • Google Ads. The Healthcare and medicines policy does not allow certain products “regardless of any claims of legality”. Its examples include products that are not government approved and are marketed as safe or effective, products subject to government or regulatory action or warning, and products with names confusingly similar to an unapproved product. Google’s list of unapproved pharmaceuticals and supplements says it is not exhaustive, so a compound’s absence from it is not a clearance.
    • Google Merchant Center. The Shopping version of the Healthcare and medicines policy uses the same unapproved substances wording for listings, and allows prescription drugs only from certified online pharmacies.
    • Prescription drug terms. Google’s restricted drug terms policy restricts prescription drug terms in ads, landing pages and keywords, and requires certification to target them in the US, Canada and New Zealand. Its October 2025 update names online pharmacies, telemedicine providers and manufacturers as the businesses that certify. An RUO supplier is none of those.
    • Meta and Microsoft. Both run their own pharmaceutical and drug ad policies. We could not open the current text of either when writing this guide, so we do not summarise them. Read Meta’s Drugs and Pharmaceuticals standard and Microsoft Advertising’s healthcare and pharmacy policy in its help centre before you plan spend on either.
    • Payment processors. Stripe’s restricted businesses list prohibits “incorrectly labeled research chemicals” and restricts card-not-present sales of prescription-only products. PayPal’s Acceptable Use Policy prohibits products that present a risk to consumer safety. Underwriters read your catalog to decide where you fall.

    All of these reviewers read the same evidence regulators read. Under 21 CFR 201.128, intended use can be shown by labeling claims, advertising matter and the circumstances of distribution. A product page is all three.

    Why one product matters

    Google’s repeat-violation procedure lists Unapproved substances by name: a warning, then account holds, then suspension after a third strike. Strikes are counted against the account, not the product. That is why the catalog sort comes before campaign building.

    2. The three risk tiers at a glance

    The tiers below are our working framework, not a platform category. They rank products by how many known triggers they carry.

    Highest riskMatches an approved drug ingredient, or FDA has named it in GLP-1 warnings
    AdsDo not advertise. Exclude from feeds, Performance Max and dynamic ads.
    PaymentsMost likely to fail underwriting or trigger review. Disclose before you list.
    Elevated riskNamed in FDA compounding safety lists or reviews, or sold as blends, kits or with supplies
    AdsExpect disapprovals. Keep out of broad campaigns; never advertise kits or bundles.
    PaymentsProcessor must know you sell it. Expect questions and possibly a reserve.
    Lower riskNot an approved drug ingredient, not named by FDA, presented with research-only facts
    AdsCandidates for Search and Shopping. Review can still disapprove.
    PaymentsStandard high-risk underwriting for the category still applies.

    Lower risk is not approval. Every tier is judged with the landing page and the rest of the site.

    TierWhat puts a product hereGoogle Ads and ShoppingMeta and MicrosoftPayment processors
    HighestName matches an approved drug’s active ingredient; compound named in FDA’s 2026 GLP-1 statementsRestricted drug term plus unapproved substances and regulatory-warning triggers. Do not advertise.Treat as not advertisable unless the current policy text clearly says otherwise for your business typeClosest to prescription-only restrictions. Highest chance of decline or termination.
    ElevatedNamed on FDA’s category 2 or withdrawn-nomination tables, reviewed at the July 2026 advisory committee, or named in a warning letter; blends and kitsRegulatory-warning trigger. Frequent disapprovals; isolate or exclude.Check current policy text before any spendMust be disclosed. Expect enhanced review.
    LowerNo approved-drug name match, no FDA mention found, accurate research-only pageMay be approved, may still be disapproved under unapproved substancesCheck current policy text before any spendNormal high-risk underwriting for the category

    Platform behaviour depends on the reviewer and the page. Tiers are a planning tool; confirm against current policy text.

    3. Highest risk: approved drug ingredients and GLP-1s

    A compound sits in the top tier when its name is the active ingredient of an FDA-approved prescription drug. Semaglutide and tirzepatide are the clearest examples. Three triggers stack on such a product at once:

    1. Restricted drug terms. The name is a prescription drug term, so its use in ads, keywords and landing pages is restricted to certified businesses.
    2. Regulatory warnings. FDA has written directly about these compounds being sold as research products.
    3. Consumer intent. Search traffic for these names is overwhelmingly about personal use, which is the use an RUO label says you do not sell for.

    What FDA said in 2026

    FDA’s page on concerns with unapproved GLP-1 drugs, current as of 1 October 2026, is the most direct statement for RUO sellers. It says FDA has warned companies that illegally sold unapproved drugs containing semaglutide, tirzepatide, retatrutide, survodutide or mazdutide that were “falsely labeled” for research purposes or not for human consumption. The same page says FDA monitors the internet and has issued warning letters to stop illegally marketed semaglutide and tirzepatide.

    On compounding, the page says retatrutide and cagrilintide “cannot be used in compounding under federal law”, that they are not components of FDA-approved drugs, and that FDA has warned telehealth companies, ingredient distributors and outsourcing facilities over retatrutide. It also says FDA is not aware of any lawful basis for compounding with semaglutide salt forms.

    FDA’s 2026 warning letters to peptide sellers point the same way. The Gram Peptides letter (31 March 2026) and the TXP Innovations letter (24 August 2026) quote product-page text about body weight, glucose and diabetes. Our RUO website compliance checklist summarises six of these letters.

    Our default for this tier

    Do not advertise these products on any paid channel, do not bid on their names, and keep them out of every product feed connected to an ad account. Whether to sell them at all is a legal decision for the owner and their counsel, and your processor must know if you do.

    4. Elevated and lower risk: what FDA’s compounding lists tell you

    Most RUO catalog items are not approved drug ingredients. Many of them have still been written about by FDA, mostly in the context of pharmacy compounding.

    The 503A bulk substance categories

    FDA’s 503A bulk substances page explains that a pharmacy may compound with a bulk substance that has a USP or NF monograph, is a component of an approved drug, or appears on the 503A bulks list. Nominated substances awaiting review are sorted into categories: category 1 may be eligible; category 2 raises significant safety risks; category 3 lacked sufficient supporting information.

    FDA’s page on bulk drug substances that may present significant safety risks, current as of 22 April 2026, lists GHRP-2, GHRP-6, ipamorelin acetate and kisspeptin-10 in its category 2 table. A second table lists substances that were previously in category 2 and whose nominations were withdrawn. It includes AOD-9604, BPC-157, CJC-1295, GHK-Cu (injectable routes), KPV, Melanotan II, MOTs-C, Semax, Selank, thymosin alpha-1 and the thymosin beta-4 fragment also known as TB-500.

    The July 2026 advisory committee

    FDA’s Pharmacy Compounding Advisory Committee met on 23 and 24 July 2026 to discuss BPC-157, KPV, TB-500, MOTs-C, emideltide (DSIP), Semax and Epitalon for the 503A bulks list. In its 23 July presentation FDA proposed that BPC-157 and its acetate not be included, and its 24 July presentation made the same proposal for emideltide. Those are FDA staff proposals, not final decisions, and we did not find posted votes or minutes. Check the meeting page for the current outcome.

    How to read these lists

    They are about compounding pharmacies, not RUO sales, and they do not say these substances are illegal to sell. For advertising they matter because Google’s policy lists “government or regulatory action or warning” as a trigger. A compound that appears in an FDA safety table belongs in the elevated tier.

    Page-level factors that make any product elevated

    • Blends and multi-compound kits. The Royal Peptides letter cited a mixed multi-pack kit and a blend.
    • Reconstitution supplies sold alongside. Several 2026 letters treated bacteriostatic water sold beside peptides as a drug.
    • Calculators and guides that describe preparation for use.

    What lower risk means

    A product belongs in the lower tier only if its name matches no approved drug ingredient, you found no FDA list or letter naming it, and its page is accurate and claim-free. Re-check this list each quarter, because FDA pages change. Lower-tier products are the only ones we would consider for Search and Shopping, and even they may be disapproved.

    5. How names and landing pages change the tier

    A compound’s tier starts with what it is. Presentation can raise it, never lower it.

    Things that raise the tier

    • Outcome or condition words in titles, descriptions or headings: weight, fat, muscle, healing, ageing, sleep or any disease name.
    • Comparisons with approved medicines, or brand drug names anywhere on the page.
    • Study summaries framed as benefits. The 2026 letters quoted “studied for” and “research shows” phrasing.
    • Dosing, administration or preparation content, and images of syringes or self-administration.
    • Reviews or testimonials describing personal results.

    Presentation examples

    ElementRaises the riskAccurate and neutral
    Product titleCompound name plus an outcome word or a brand drug comparisonCompound name, amount per vial, purity, “for laboratory research use only”
    DescriptionSummaries of what studies suggest it does in the bodySequence or formula, molecular weight, form, storage, lot and certificate of analysis
    ImagesSyringes, people, before-and-after visualsBrand graphics, lab-setting images and documentation
    Related itemsBacteriostatic water, kits and calculators on the same pageOther research materials and documentation

    Things that do not lower it

    • Disclaimers. Google applies its policy regardless of any claims of legality, and FDA’s letters looked past research-use labels.
    • Coded names. Nicknames, abbreviations, misspellings or numbers in place of a compound name do not change the product. Google’s Circumventing systems policy treats attempts to evade review as a violation in its own right, and the unapproved substances policy covers names confusingly similar to an unapproved product.
    • Separate domains or hidden pages. Moving a product does not change what it is, and showing reviewers different content is cloaking.

    Our product page template and feed optimization guide show accurate, claim-free titles and pages. For keyword choices by risk, see peptide keyword research.

    6. Structuring the catalog and campaigns

    The goal is that ads only ever point at products you have decided to advertise, and that every reviewer sees the same site customers see.

    In the catalog

    • Tag every product with a tier in your store, and record the reason and the date you checked it.
    • Keep tier tags in the feed as custom labels so you can filter Shopping and Performance Max campaigns by them.
    • Exclude highest-tier products from ad destinations. Merchant Center’s excluded destination attribute keeps a product out of Shopping ads and other destinations. Elevated products should usually be excluded too.

    In the ad account

    • Build Search and Shopping around lower-tier products and brand terms. Send ads to product or category pages that contain only those items.
    • Do not run broad, feed-wide Performance Max. Limit listing groups to lower-tier labels, and add brand-safe negative keywords. Our guide to Performance Max for peptides covers the setup.
    • Turn off automatically created dynamic ads that can pick up any page on the domain.
    • Never retry a disapproved product with a renamed copy. Fix the page or stop advertising it.
    What separation does and does not do

    Separating campaigns stops high-risk products from being submitted for review over and over, which limits strikes. It does not shield the account from what is on the website, because Google reviews the destination and the business behind it. If you are already dealing with a suspension, start with our suspension recovery guide and our Merchant Center recovery service.

    On Meta and Microsoft

    Plan these channels from the current policy text, not from what worked for another store. Start with brand and lower-tier products only, read every rejection reason, and stop a campaign rather than appeal repeatedly with small wording changes. Microsoft Advertising can import Google Ads campaigns, so check that excluded products and negative keywords carry across before any import goes live.

    With payment processors and email

    • Disclose the whole catalog, including every highest and elevated item, to every processor. A processor that discovers an undisclosed product line can close the account and hold funds. Our chargebacks and processor redundancy guide covers honest disclosure.
    • Apply the same tiers to email. Campaigns are advertising matter too; feature lower-tier products and keep claims out.

    Our services for Google Ads for peptides, Google Shopping for peptides, peptide email marketing and peptide payment processing all start from this sort.

    7. The catalog risk-sort checklist

    Run this before any campaign, then quarterly
    1. Export the full catalog, including variants, kits and supplies.
    2. Check each name against approved drug ingredients. Any match goes to highest risk.
    3. Check FDA’s 2026 GLP-1 statement. Any compound it names goes to highest risk.
    4. Check FDA’s compounding safety tables and advisory committee pages. Any compound named goes to elevated.
    5. Search fda.gov warning letters for each compound name. Any match goes to elevated or higher.
    6. Mark blends, kits and anything sold with reconstitution supplies as elevated.
    7. Read every lower-tier page and remove outcome words, study-benefit framing, dosing and testimonials.
    8. Add tier custom labels to the feed and set excluded destinations for highest and elevated items.
    9. Rebuild campaign product filters so only lower-tier labels can serve.
    10. Remove highest-tier names from keywords and add them as negatives.
    11. Send your processor the updated catalog and keep the confirmation.
    12. Record the date and sources checked, and repeat next quarter.

    8. FAQ

    Which peptides can be advertised on Google?

    Google publishes no list of approved peptides. Its unapproved substances policy applies regardless of any claims of legality and its list is not exhaustive. In our experience only accurately presented, lower-risk products are realistic candidates, and they can still be disapproved.

    Can I advertise semaglutide or tirzepatide as research products?

    We advise against it. Both are active ingredients of approved prescription drugs, so restricted drug term rules apply, and FDA’s 2026 GLP-1 page says it has warned companies selling them falsely labeled for research purposes.

    Does a research-use-only disclaimer change the risk tier?

    No. Google’s policy applies regardless of claims of legality, and FDA’s 2026 warning letters looked past research-use labels to the product pages. The tier depends on what the product is and how it is presented.

    Is BPC-157 banned?

    FDA’s compounding pages list BPC-157 among substances previously in category 2 whose nominations were withdrawn, and in July 2026 FDA proposed it not be added to the 503A bulks list. Those pages concern compounding. For advertising, that regulatory attention puts it in the elevated tier.

    Will excluding high-risk products protect my ad account?

    It reduces repeated disapprovals and strikes, but it does not hide the website. Google reviews destinations and the business, so the whole site needs to be accurate and claim-free.

    Can I rename a product so it passes review?

    No. Coded or similar names do not change the product, Google’s policy covers confusingly similar names, and evading review is a separate violation under its Circumventing systems policy.

    Do I need to tell my payment processor about high-risk products?

    Yes. Give every processor the full, accurate catalog. An undisclosed product line can lead to termination and held funds.

    Need a second opinion?

    Get your catalog sorted before you spend

    Peptide Marketing works only with research-use-only peptide brands. We will go through your catalog, feed and landing pages, assign each product a risk tier, and tell you which campaigns we would build first. We do not help disguise products or work around platform policies.

    Book a 15-min call

    Prefer email? Write to hello@peptidemarketing.info.

    Sources

    General information for businesses selling research-use-only products, not legal or regulatory advice. Sources read on 16 November 2026; policies and FDA pages change.